Stress (Heat Shock) Proteins

Molecular Chaperones in Cardiovascular Biology and Disease

From the Department of Internal Medicine and Integrative Biology Graduate Program, Molecular Cardiology Research Laboratories, The University of Texas Southwestern Medical Center, Dallas, Tex.

Correspondence to Ivor J. Benjamin, MD, Molecular Cardiology Research Laboratories and Integrative Biology Graduate Program, U.T. Southwestern Medical Center, Dallas, TX 75235-8573. E-mail benjamin{at}ryburn.swmed.edu

	Abstract

Top Abstract Introduction Definitions and Nomenclature Stress Proteins Can Function... The Case for Molecular... Molecular Chaperones of the... Molecular Chaperones in ER Current Challenges and Future... Does Stress-Inducible Expression... Molecular Chaperones and Cell... Perspectives References

 
Abstract—How a cell responds to stress is a central problem in cardiovascular biology. Diverse physiological stresses (eg, heat, hemodynamics, mutant proteins, and oxidative injury) produce multiple changes in a cell that ultimately affect protein structures and function. Cells from different phyla initiate a cascade of events that engage essential proteins, the molecular chaperones, in decisions to repair or degrade damaged proteins as a defense strategy to ensure survival. Accumulative evidence indicates that molecular chaperones such as the heat shock family of stress proteins (HSPs) actively participate in an array of cellular processes, including cytoprotection. The versatility of the ubiquitous HSP family is further enhanced by stress-inducible regulatory networks, both at the transcriptional and posttranscriptional levels. In the present review, we discuss the regulation and function of HSP chaperones and their clinical significance in conditions such as cardiac hypertrophy, vascular wall injury, cardiac surgery, ischemic preconditioning, aging, and, conceivably, mutations in genes encoding contractile proteins and ion channels.

Key Words: stress protein • gene expression • molecular chaperone • transcription factor • vascular biology • aging • ischemia

	Introduction

Top Abstract Introduction Definitions and Nomenclature Stress Proteins Can Function... The Case for Molecular... Molecular Chaperones of the... Molecular Chaperones in ER Current Challenges and Future... Does Stress-Inducible Expression... Molecular Chaperones and Cell... Perspectives References

 
Physiological stresses ranging from myocardial ischemia to genetic mutations produce disease states in which protein damage and misfolded protein structures are a common denominator.^{1 2 3 4 5 6 7 8 9} How does the cell respond? Multiple endogenous pathways are engaged in restoring cellular homeostasis, but one well-characterized mechanism that involves protein folding is the heat shock family of stress proteins, or HSPs.^{10 11} Insight into the mechanisms underlying HSP function is provided by 2 main lines of evidence: (1) the correct folding of many proteins in a cell requires protein-folding machinery, the molecular chaperones,^{12 13} and (2) HSP chaperones repair denatured proteins or promote their degradation after heat shock.^{14 15}

Genetic studies provide convincing proof in different phyla that overexpression of stress proteins is a powerful means of cytoprotection, even in the intact heart.^{10 16 17 18} Similarly, biochemical studies have demonstrated that the Hsc70 chaperone increases the productive folding of the common F508 mutation of CFTR. This suggests a physiological role of an HSP chaperone in human diseases.^{19 20} Divergent mechanisms that produce abnormal or misfolded cellular proteins converge into a common pathway, leading to an increase in the levels of cytoprotective stress proteins, which decrease or neutralize the deleterious effects of acute or chronic stresses.

In this review, we summarize present knowledge about the regulation and function of individual chaperones (eg, Hsp90, Hsp70, Hsp60, Hsp47, Hsp27, and B-crystallin) in the cardiovascular system. Besides their well-established roles in cell survival (necrosis and apoptosis), we will emphasize the emerging evidence regarding chaperone functions in physiological adaptation during cardiac hypertrophy, ischemic preconditioning, vessel wall injury, oxidative stress, and aging. Although we presently can only speculate about their roles in specific cardiac diseases, we will discuss many potential opportunities to establish whether HSP chaperones either exert an effect on or play a direct physiological role in the natural history of diseases resulting from mutations of cardiac contractile apparatus (eg, hypertrophic cardiomyopathy) and ion channels (eg, long-QT syndrome) in humans.

	Definitions and Nomenclature

Top Abstract Introduction Definitions and Nomenclature Stress Proteins Can Function... The Case for Molecular... Molecular Chaperones of the... Molecular Chaperones in ER Current Challenges and Future... Does Stress-Inducible Expression... Molecular Chaperones and Cell... Perspectives References

 
What Are Stress "Heat Shock" Proteins?
The term "heat shock" protein is a misnomer but remains as a legacy of Ritossa's serendipitous discovery²¹ that heat shock produced chromosomal puffs of salivary gland cells in Drosophila. Heat stress (5° above normal growth temperature) upregulates the rapid synthesis of a multigene family of proteins, originally called heat shock proteins,²² which are the result of a response often referred to as the heat shock response.^{10 21} Prior sublethal heat stress transiently increases the ability of a cell to withstand an otherwise lethal subsequent heat challenge. This phenomenon, or thermotolerance, played a key role in launching numerous studies in both in vitro and in vivo experimental models in which a similar association was found between the heat shock response and protection against either simulated hypoxia or ischemia. Indeed, diverse stresses, including heavy metals, amino acid analogues, inflammation, and oxidative/ischemic stress, induce the expression of HSP genes. Consequently, the terms "stress proteins" or "heat shock family of stress proteins" are preferred, although many of these proteins have essential functions during unstressed conditions.¹³

Stress proteins belong to multigene families that range in molecular size from 10 to 150 kDa and are found in all major cellular compartments. The convention is to name stress proteins of various molecular sizes as follows: Hsp27, Hsp70, and Hsp90; whereas heat shock protein genes are designated as follows: hsp27, hsp70, and hsp90.²³ The distinction between constitutively expressed (eg, Hsc70 and Hsp90ß) or cognate members of the HSP family and their inducible isoforms (Hsp70 and Hsp90, respectively) is arbitrary, since accumulating evidence, in physiologically relevant in vivo systems, now indicates that such relationships depend on cell- and tissue-restricted expression.

Cellular Consequences of Heat and Ischemic Stress Are Similar
Like experimental ischemia/reperfusion, heat shock is a stress that disrupts numerous metabolic processes and cellular structures and that culminates in cell death when a critical threshold is exceeded.^{10 24 25} Both heat stress and ischemia cause extensive damage to the cytoskeleton, including collapse of the threadlike intermediate filament network into large perinuclear aggregates, reorganization of the cytoplasmic network, relocalizaton of actin-containing fibers around the nucleus, and disruption of microtubules and the mitotic spindle.^{26 27} Mitochondrial swelling, loss of mitochondria, and uncoupling of oxidative phosphorylation are similarly shared features of heat shock and early reversible ischemic injury.^{28 29 30}

Characteristically, general protein synthesis is inhibited after extreme heat challenge as a result of phosphorylation of initiation factors such as eIF2, which disrupts ribosomal assembly and inactivates cap-binding proteins.^{31 32 33} In contrast, HSP genes are efficiently expressed after heat challenge, in part, as a result of the absence of introns in several inducible (eg, hsp70) genes. In addition, alterations of mRNA splicing and heat-induced stabilization of mRNA are adaptive mechanisms used to efficiently translate stress proteins, which can reach 15% to 25% of total intracellular protein within minutes after physiological stress under these conditions.^{10 34} Coincidentally, several cytosolic chaperones translocate into the nucleus,³⁵ where heat-induced inhibition of DNA chromatin assembly exposes a nuclease-sensitive conformation, a pathognomonic feature of both heat- and ischemia-induced apoptosis.³⁶ Less dramatic changes are seen in integral membrane proteins, the lipid bilayer, and cellular surface morphology. Cessation of noxious stimuli is followed by rapid and efficient degradation of Hsp mRNAs.^{37 38 39}

As mentioned previously, prior sublethal heat stress or "hyperthermic preconditioning" profoundly attenuates all of the heat-induced cellular changes to a subsequent severe heat challenge. Moreover, pretreatment with heat produces "cross tolerance" to varying types of physiological stress. For example, protection of the intact ischemic heart after heat pretreatment may last for hours to days.^{40 41} Insight gained from the physiological roles of Hsp expression during the heat shock response has contributed to current thoughts about chaperone functions in pathological states likely to result in abnormal protein folding.

Attention has primarily focused on the induction of HSP chaperones and the potential repair mechanisms involved in mitigating ischemia/reperfusion injury. Figure 1 schematically summarizes many of these concepts and illustrates the multiple well-recognized mechanisms implicated in ischemic myocardial injury, including oxidative stress/damage, calcium overload and activated proteases, release of proteolytic and lysosomal enzymes, alterations of the cytoskeleton, and complement activation.

View larger version (44K): [in this window] [in a new window]   Figure 1. A summary of the major pathophysiological signals that activate HSP synthesis (left of vertical solid line) and the potential functions of HSPs (right of vertical solid line). Cellular injury is manifested by increased generation of ROS, availability of redox-active iron, peroxidation of membrane lipids, and protein damage, among others.92 The extracellular sources of ROS (A) could be endothelial cells, VSMCs, and even myocytes in the surrounding tissue; mitochondrial electron transport of molecular oxygen (B) may be the main intracellular source for ROS generation. Intracellular free calcium (C), which increases 10-fold within 10 minutes of reperfusion,228 229 has been implicated in the activation of proteases (D), which, in turn, are thought to contribute to intracellular myocardial injury.230 231 232 Damage to the cytoskeleton (E) is an early event of ischemic injury, which causes ventricular dysfunction or "myocardial stunning" when the injury is reversible.87 Myocardial injury could also occur from recruitment of polymorphonuclear leukocytes (PMNs) by multiple mechanisms into the ischemic territory and by the release of oxygen-derived free radicals (A), cytotoxic lysosomal enzymes (F), extracellular proteases (G), and complement activation (H) (reviewed in Reference 233). Diverse physiological signals are thought to activate the stress-inducible HSF1 (I), which binds to the sequence-specific heat shock element (HSE) (J), contained in the promoters of all HSPs (K). Although the precise mechanism of Hsp70-mediated ischemic protection is poorly understood, it is widely attributed to the biological property of "molecular chaperones," which are proposed to assist in the assembly or repair of newly synthesized or damaged proteins.11 234 235 In physiological terms, potential functions for molecular chaperones in the ischemic heart include the following: protein folding of newly synthesized polypeptides essential for maintaining oxidative metabolism after myocyte damage (L), protection of mitochondria from ROS and cytokines such as TNF204 236 and translocation of newly synthesized proteins during organelle repair (M), repair of critical structural proteins after ischemia-induced cytoskeletal alterations (N),237 recycling of membrane vesicles (Hsc70) (O), transport of potential toxic byproducts for degradation by the proteasome (P),78 238 239 suppression of proinflammatory cytokines such as pro–interleukin-1ß (Q),204 236 240 suppression of NADPH oxidase and the oxidative burst by the heat shock response (R),241 protection by NO production from inducible synthesis of HSP expression (S),61 242 243 244 245 246 prevention of apoptosis either through the mitochondrial chaperone Hsp60 binding of cytochrome c and/or Hsp70 binding of cytosolic targets (T),36 204 repair of ion channel (U), collagen synthesis by Hsp47 chaperone for reparative fibrosis (V),180 and modulation of the immune-mediated ischemic injury (W).241

Diverse Physiological Stresses Induce HSP Gene Expression Through a Common Mechanism
Rapid induction of stress protein expression is accomplished through mechanisms of transcriptional activation and preferential translation.^{10 42} HSFs (HSF1 through HSF4) regulate the inducible synthesis of HSPs during development, growth, and adaptation.^{42 43 44} Whereas essential single-copy genes encode HSF in Saccharomyces cerevisiae and Drosophila,^{45 46} multiple HSFs have been identified in chicks, plants, mice, and humans.^{47 48 49 50 51} Two HSFs (HSF1 and HSF2, encoding proteins of 75 and 72 kDa, respectively) have been identified in the mouse.⁴⁹ Neither HSF1 nor HSF2 is heat inducible, but HSF1 is hyperphosphorylated in a ras-dependent manner by members of the MAPK subfamilies (ERK1, JNK/SAPK, and p38 protein kinase) during physiological stress.^{52 53} During unstressed conditions, both DNA-binding activity and transcriptional activity of vertebrate HSF1 are under tight negative control (reviewed in Reference 44⁴⁴ ). However, it remains controversial whether repression by chaperone Hsp70, sequestration of constitutive phosphorylation on serine residues, or unknown inhibitory regulators are the principal mechanisms underlying stress-inducible activation and rapid deactivation of HSF1.^{43 54 55 56}

Previous studies have demonstrated that in response to both heat and simulated ischemia, the mechanism(s) for HSF1 activation is similar, if not identical, in myogenic cells⁵⁷ and that depletion of intracellular ATP plays an important role in triggering the HSF1-DNA binding activity.⁵⁸ In disease conditions, inducers of HSF1 activation, such as oxidized LDL and reactive nitrogen intermediates, are thought to increase protein damage, which triggers upregulation of HSP gene expression.^{59 60 61} However, transcriptional activation of the HSF1 pathway does not require new protein synthesis, since the preexisting transactivator (HSF1) is inactive in the unstressed state.^{43 56 57} Physiological stresses, such as heat and ischemia, induce HSF1 monomers to oligomerize as homotrimers, which then bind to an upstream sequence-specific motif, heat shock element, in the promoter of all stress-inducible HSP genes^{62 63} (Figure 1I through 1K). We recently established a gene knockout model of Hsf1 and demonstrated in in vitro studies the essential requirement of this regulatory pathway in cellular defense and thermotolerance.³⁶ In addition, stress protein expression has been implicated in promoting tumor cell survival⁶⁴ and protection of the ischemic heart.^{16 17 18}

Stress Protein Overexpression Enhances the Speed of Physiological Recovery of the Ischemic Heart
A substantial literature describes the induction of Hsp70 by ischemia,^{57 65 66} the potential role of Hsp70 in ischemic preconditioning,^{40 67} and an inverse correlation between expression of Hsp70 induced by ischemic or thermal preconditioning and infarct size in animal models.^{41 68 69 70} In addition, forced expression of Hsp70 conveys a cytoprotective effect in cultured cells, including cardiac myocytes subjected to simulated ischemia.^{71 72} Specifically, overexpression of the major 70-kDa heat shock protein (Hsp70) in transgenic mice improves myocardial function,^{16 17 18} preserves metabolic functional recovery,¹⁸ and reduces infarct size⁷³ after ischemia/reperfusion. In addition to Hsp70, Hsp27 and B-crystallin can protect primary cardiomyocytes against ischemic damage.⁷⁴ Although the precise mechanisms are insufficiently understood, stress proteins are thought to mediate cardioprotection through their biological functions as molecular chaperones.

	Stress Proteins Can Function as Molecular Chaperones

Top Abstract Introduction Definitions and Nomenclature Stress Proteins Can Function... The Case for Molecular... Molecular Chaperones of the... Molecular Chaperones in ER Current Challenges and Future... Does Stress-Inducible Expression... Molecular Chaperones and Cell... Perspectives References

 
Molecular chaperones, like Hsp70 and B-crystallin, are proteins that facilitate the folding, assembly, and disassembly of other proteins but are not part of the finished product.⁷⁵ Since many proteins require chaperones to fold, these proteins are essential components in the final stage of the central dogma of molecular biology: DNARNApolypeptidefolded protein.^{11 75} In vitro chaperones function to prevent aggregation of other proteins under conditions of stress and to promote restoration of enzymatic activity of denatured protein substrates or enzymes (eg, citrate synthase, ß-galactosidase, or luciferase) on removal of the stress.^{11 13 76}

Figure 2 shows schematically the reaction cycle of chaperone Hsc70 in relation to recently identified cochaperones and molecular substrates in the cell. For example, chaperone Hsp40 plays a major catalytic function in loading target substrates onto the Hsc70 binding/release cycle.⁷⁷ Although the mechanisms of these functions are still emerging, the major functions of molecular chaperones are to (1) transiently bind and delay the folding of nascent polypeptide chains until synthesis is complete, (2) maintain polypeptide chains in an appropriate conformation suitable for translocation across organelle membranes, (3) prevent aggregation from intramolecular or intermolecular interactions, (4) actively disassemble clathrin-coated vesicles, (5) hold steroid aporeceptor complexes in ligand competent states (Hsp90 and cochaperone), and (6) assist in degrading toxic metabolites by promoting ubiquination and proteasome lysis⁷⁸ (Figure 1L through 1P).

View larger version (31K): [in this window] [in a new window]   Figure 2. A proposed scheme for the reaction cycle of chaperone Hsc70 complex in folding of a hypothetical substrate in the cell. Starting at the bottom of the figure, chaperone Hsc70 (A) consists of an N-terminal ATPase and C-terminal domain for binding target substrate. Hsp40 (B), the eukaryotic homologue of DnaJ, either binds unfolded proteins (UPs) first (C) and then binds Hsc70.ADP, or it binds to the Hsc70.ADP.UP complex (D), which has a low on/off rate for UPs. Several different fates for the Hsc70.ADP.UP complex are envisioned, each of which depends on the replacement of Hsp40 by different accessory partners, specifically, Hip (Hsc70-interacting protein), Hop (Hsc70/Hsp90-organizing protein), and Hap (Hsc70 accessory protein).166 247 248 After Hsp40 is released, Hip binds to the ATPase domain of Hsc70 (E), stimulates its activity, and then remains bound to stabilize the ADP-Hsc70-substrate complex, suggesting that it may play a role in the transport of substrates within cells (F).166 Hop serves as a physical linker between Hsc70 and Hsp90 (G), presumably to facilitate the transfer of UPs between these chaperones. Whether or not Hop changes the ATPase activity of Hsc70 is controversial.249 The function of Hup, which stimulates the release of UPs from Hsc70 (H) and converts oligomers of Hsc70 into monomers (I), remains to be established. The energy transferred from ATP hydrolysis, the rate-limiting step of the eukaryotic chaperone cycle, is used in successive cycles to assist folding and prevent aggregation and degradation. To this end, two related proteins, BAG-1 (not shown) and Hap (J), which bind to the Hsc70 ATPase domain, also inhibit binding of Hsp70 to unfolded protein substrate in vitro, suggesting that these proteins may play roles in maintaining quality control by directing nonproductive interactions toward degradation250 (illustration kindly provided by L.E. Hightower, University of Connecticut, Storrs).

	The Case for Molecular Chaperones in Cardiac Diseases

Top Abstract Introduction Definitions and Nomenclature Stress Proteins Can Function... The Case for Molecular... Molecular Chaperones of the... Molecular Chaperones in ER Current Challenges and Future... Does Stress-Inducible Expression... Molecular Chaperones and Cell... Perspectives References

 
Widespread clinical interest into the biological functions of molecular chaperones extends over a range of human pathologies from degenerative conditions such as Alzheimer's disease, prions, amyloidosis, cataract formation, sickle cell disease, cystic fibrosis, and various cardiac diseases including myocardial ischemia. Early events that reestablish timely reflow of the ischemic myocardium either through thrombolytics, direct angioplasty, or spontaneous clot lysis are essential for enhancing myocardial salvage and reducing morbidity and mortality.^{79 80} Nonetheless, recurrent ischemia either from rupture of an unstable plaque or congestive heart failure can complicate the clinical course of an acute myocardial infarction. In uncomplicated acute myocardial infarction, physiological recovery at the cellular level begins within minutes but could last for weeks to months before myocardial repair is complete. Thus, endogenous protective mechanisms have clinical relevance in mitigating the effects of ischemic heart disease.

Biochemical Activities of HSP Regulatory Pathway and Chaperones During Myocardial Ischemia
In previous work undertaken to define the proximate stimulus to HSF activation, we observed that severe intracellular acidosis (pH 6.7) was insufficient to induce the DNA binding of HSF1 in cultured myogenic cells exposed to simulated ischemia, if ATP stores were preserved.⁵⁸ In contrast, severe ATP depletion (65%) stimulated DNA binding of HSF1, even if pH was maintained within the normal range.⁵⁸ In the intact ischemic heart, 15 minutes of ischemia, which produces reversible injury, is associated with a similar reduction (65%) of high-energy ATP stores, whereas lethal injury is found with prolonged ischemia (>40 minutes) and >90% depletion of high-energy pools.⁸¹ The K_m for the weak ATPase activity of bovine Hsc70 is 1 to 2 µmol/L, 3 orders of magnitude below the millimolar concentrations of intracellular adenine nucleotide pools.⁷⁵ Therefore, ATP-dependent activation of the HSF1 regulatory pathway and the biochemical properties of molecular chaperones are unlikely to be adversely affected during periods of transient ischemia or reversible myocardial ischemic injury.

Proof of principle indicating a cardioprotective effect of Hsp70 in transgenic animals subjected to ischemia/reperfusion suggests that pharmacological or genetic methods to increase stress protein expression in the myocardium of patients at risk of acute ischemic events might limit ischemic injury.⁸² However, additional basic knowledge is needed regarding (1) their relationships to other endogenous pathways involved in myocardial protection from oxidative stress/damage, (2) functional specificity among chaperone members of the HSP multigene family, and (3) the contribution of this pathway during acute ischemia and other physiological states that trigger the heat shock response, before clinical application.

Stress Proteins and Antioxidant Pathways for Cardioprotection
Since the 1970s, the hypothesis that free radical scavengers can ameliorate oxidative damage during ischemia/reperfusion has been pursued by clinicians and researchers.⁸³ In model systems ranging from transgenic Drosophila to mice, overexpression of catalase, superoxide dismutase, or glutathione peroxidase tends to be protective against oxidative stress.^{84 85 86} Oxidative stress, from ischemia/reperfusion, also plays a central role in the injury of vital organs such as the brain, kidney, and heart. ROS are thought to contribute to ventricular dysfunction, or "myocardial stunning," arrhythmias, and progressive cell damage or death after ischemic injury (Figure 1).^{87 88 89 90}

Discrepant results have been reported from attempts to deliver antioxidants during and after myocardial ischemia/reperfusion.^{91 92} Exogenous antioxidants, which are restricted to the interstitial spaces, may have limited ability to protect intracellular proteins against ROS. For example, the hydroxyl free radical (·OH), believed to be the main agent of oxidative damage, is so highly reactive with a typical substrate that its half-life at 37°C is 7x10^-10 seconds.⁹³ Thus, it is difficult to envision that the administration of exogenous antioxidants, at concentrations that are physiologically feasible, can effectively prevent ·OH-induced macromolecular damage. A potentially more effective strategy may be to physiologically minimize the production of ·OH. Indeed, overexpression of members of the HSP family may provide one such avenue. Several studies have reported that during protection against myocardial ischemia, upregulation of stress protein levels correlates with increases in the enzymatic activity of catalase, suggesting potential additive or synergistic interactions of these endogenous pathways against oxidative stress.^{40 94 95} An important unanswered question is whether functions of stress proteins, as molecular chaperones, complement the unique functions of antioxidant enzymes in protecting against oxidative stress/damage.

	Molecular Chaperones of the Cytosol/Nuclear Compartments

Top Abstract Introduction Definitions and Nomenclature Stress Proteins Can Function... The Case for Molecular... Molecular Chaperones of the... Molecular Chaperones in ER Current Challenges and Future... Does Stress-Inducible Expression... Molecular Chaperones and Cell... Perspectives References

 
The Table shows the major classes of HSPs, the intracellular compartments, their putative functions, and potential significance in cardiovascular biology.

Hsp70 Chaperones
Members of the Hsp70 family are the most widely studied and abundant group in eukaryotic cells.⁹⁶ In the cytosol, Hsp70 binds to nascent polypeptides before their release from the ribosome.⁹⁷ All members of the Hsp70 chaperone class possess two distinct domains: a highly conserved N-terminal ATPase domain and a more divergent C-terminal domain, which binds short hydrophobic peptides of target substrates^{98 99} (Figure 2A). Hsp70 chaperone function requires the N-terminal ATPase domain, which, interestingly, is similar structurally to rabbit skeletal muscle actin despite little sequence similarity.¹⁰⁰

These structure/functional relationships of Hsp70 likely confer in vivo chaperone activity in cardioprotection. In this regard, virtually nothing is known about the constitutive Hsc70 chaperone, which shares >80% sequence homology with Hsp70. Conceivably, modest upregulation of the constitutive Hsc70 could promote substantial cardioprotective benefit. However, upregulation of HSPs beyond a critical threshold may have deleterious cellular consequences.¹⁰¹ Distinct functions between Hsp70 members were reported recently to exist in regions outside the peptide binding domain, suggesting additional levels of complexity to chaperone functions in vivo.¹⁰²

Hsp90 Chaperones
Figure 2 shows that the chaperone Hsp90 is a component of the reaction cycle involving the chaperone Hsc70 complex and newly synthesized proteins. In addition, members of the Hsp90 family, Hsp90 and Hsp90ß, which constitute 1% to 2% of the total soluble cytoplasmic proteins, have the best characterized in vivo functional relationships with target proteins, the steroid hormone receptors.¹⁰³ Hsp90 with chaperone partners, Hsp70 and Hsp56, directly binds, stabilizes, and maintains the aporeceptor complex in an inactive conformation. Ligand binding (eg, estrogen) to the aporeceptor complex triggers ATP hydrolysis by Hsp90, which dissociates from an "activated" receptor that can now bind to the sequence-specific recognition motif and induce the transcription of target genes.¹⁰⁴ In addition, elevated levels of Hsp90 expression destabilize the estrogen receptor/estrogen responsive element complex and downregulate estrogen-responsive target gene expression, indicating a regulatory feedback loop.¹⁰⁵

Hsp90 chaperone functions are mediated by signal transduction pathways involving various protein kinases of both tyrosine and serine-threonine types, casein kinase II, the heme-regulated eIF-2, and a variety of other cellular proteins, such as calmodulin, actin, and tubulin (reviewed in Reference 106¹⁰⁶ ). Finally, Hsp90 chaperones of Saccharomyces cerevisiae are essential for survival under all conditions, supporting their important physiological roles in lower eukaryotes.¹⁰⁷

Cytosolic Chaperones of Special Interest in Cardiac and Vascular Biology
Unlike the ubiquitous Hsp70 and Hsp90 counterparts, specific members of the small MW HSPs (HO-1 or Hsp32, Hsp27, B-crystallin, and Hsp20 chaperones) exhibit tissue-restricted expression, suggesting potential specialized properties in the cardiovascular system.

Inducible HO (Hsp32)
HO is the rate-limiting enzyme in the degradation of heme to biliverdin (a potent antioxidant), molecular iron, and carbon monoxide. Three related single-copy genes encode HO isoforms: HO-1, HO-2, and HO-3.^{108 109 110} HO-1 is a bona fide 32-kDa stress protein (Hsp32) that is induced by diverse physiological stresses, including hypoxia, ischemia/reperfusion, hemin, hydrogen peroxide, and several heavy metals (selenium, arsenite, cobalt, cadmium, and stannous ions).^{108 109 110} Inducible Hsp32 (HO-1), the most widely expressed isoform, is present in myocardial cells.¹¹¹

Hsp32, like the inducible form of NO synthase mediates guanylyl cyclase–dependent platelet inhibition and vasodilation of VSMCs.^{112 113 114} However, physiologically relevant hemodynamic forces (shear stress and cyclic strain) induce HO-1 mRNA expression but not inducible NO synthase expression, suggesting specificity of this stress response pathway to physiological signals.¹¹⁵ Either endogenously released or exogenous administered NO induces a 3- to 6-fold increase in Hsp32 (HO-1) gene expression and CO production in VSMCs¹¹⁶ ; similarly, the inhibitor tin protoporphyrin-IX prevents platelet aggregation through induction of HO-1 gene expression and CO production in aortic VSMCs.¹¹⁵ In rat VSMCs, angiotensin II treatment decreases Hsp32 (HO-1) mRNA expression in a calcium-dependent manner.¹¹⁷ However, angiotensin II–induced hypertension increases Hsp32 (HO-1) mRNA expression in rat aorta, suggesting the overriding influences of hemodynamic factors in vivo.¹¹⁸

Several regulatory pathways are involved in the induction of Hsp32 gene expression, most notably the HSF1 and the hypoxia-inducible transcription factor-1 pathways.^{119 120 121 122} Although direct evidence of a chaperone function of Hsp32 is lacking, its overexpression in several cell types protects against oxidative stress/damage.^{123 124 125} Accordingly, studies to define the precise regulatory pathways stimulated by heavy metals, hypoxia, and oxidative stress could provide novel insight into the biological roles of Hsp32 (HO-1) in modulating oxidative stress/damage during ischemia/reperfusion, vascular tone (eg, hypertension), and inhibition of platelet aggregation and/or VSMC proliferation after balloon angioplasty.

Hsp25/27 Chaperone
After its discovery as an inhibitor of actin polymerization,¹²⁶ chaperone Hsp 25/27 (Hsp25 in mice and Hsp27 in humans) has been demonstrated to play a major role in actin filament dynamics in diverse cell types. Physiological stimuli (oxidative stress, cytokines, and growth factors) dramatically increase the phosphorylation of human Hsp27 at Ser15, Ser78, and Ser83 residues, which is essential for acquired tolerance.^{127 128 129} Hsp25/27 phosphorylation is catalyzed by the MAPKs (p38-MAPKs, JNKs, or SAPKs) and ERKs.¹³⁰ In the perfused adult heart, both p38-MAPK and JNK/SAPK are activated after ischemia/reperfusion.¹³¹ In response to ROS treatment, activation of p38-MAPK increases MAPKAP kinase 2 activity, which phosphorylates Hsp27.¹³²

In human endothelial cells, inhibition of vascular endothelial growth factor–induced p38-MAPK activation abolishes Hsp27 phosphorylation, actin polymerization, and cell migration, suggesting a possible link between Hsp27 and angiogenesis.¹³³ Together, available evidence places the p38-MAPK as an upstream activator of stress-inducible Hsp25/27 phosphorylation, and this pathway underlies the effect of p38-MAPK on the reorganization of filamentous actin, accumulation of stress fibers, and the recruitment of vinculin at focal adhesion sites.¹³⁴ It will be important next to determine whether Hsp25/27 exerts vasoprotective actions in response to hemodynamic forces or vessel wall injury. However, direct analysis will likely require an Hsp27 gene knockout model.

B-Crystallin Chaperone (Hsp22)
Whereas Hsp27 is detected in endothelial cells, VSMCs, and cardiomyocytes, the B-crystallin chaperone is expressed in cardiomyocytes only.¹³⁵ Both Hsp27 and B-crystallin are structurally related bona fide HSPs with in vitro chaperone activity but, unlike Hsp70, are not ATP-binding proteins.^{136 137 138 139} Heightened interest into the regulation and function of B-crystallin protein (Hsp22), a major structural protein of the ocular lens, is related to its tissue-restricted expression in striated myogenic lineages with high oxidative capacity, such as the heart and type I skeletal muscle fibers.¹⁴⁰ In nonlenticular tissues, B-crystallin postnatal expression increases and reaches its highest levels in the adult heart (1% to 3% of the total soluble protein), followed by skeletal muscle and the kidney.¹⁴⁰ Previous immunohistochemical studies have localized the highest B-crystallin expression in the cardiac conduction fibers of the adult heart.¹⁴¹ Whether an alteration of B-crystallin expression could lead to abnormalities of the conduction system is presently unknown but raises an intriguing possibility.

Although B-crystallin expression has been localized to Z bands of the cytoskeleton, in a pattern similar to desmin and actin,¹⁴² recent studies suggest that this interaction is much more transient and dynamic with respect to intracellular targets, depending on the physiological conditions. In unstimulated cardiac myocytes, biochemical studies indicate that B-crystallin is highly soluble and remains in the cytosolic fraction; heat or ischemia triggers rapid translocation of B-crystallin into the insoluble cytoskeletal/nuclear fractions, aggregation, and specific interactions at Z bands (Reference 142¹⁴² and I.J. Benjamin, unpublished data, 1998). The physiological significance for the tendency of both B-crystallin and Hsp25/27 to form large hetero-oligomeric complexes (500 to 800 kDa) both in vivo and in vitro after physiological stresses remains a mystery.^{143 144} Although B-crystallin chaperone provides cytoprotection to cardiomyocytes,⁷⁴ the regulatory mechanisms of posttranslation modifications such as phosphorylation, glycation, and deacetylation on B-crystallin function await direct analysis in the cardiovascular system.

Stress Proteins and Striated Muscle Development and Differentiation
Increased small MW HSP chaperone expression has been described during periods associated with increased protein synthesis, protein degradation, and cellular reorganization, such as myogenic differentiation and embryogenesis.¹⁴⁵ The tissue-restricted expression of B-crystallin during skeletal muscle myogenesis may require the MyoD family of basic helix-loop-helix transcription factors, which bind the essential E-box enhancer contained in B-crystallin promoter.^{146 147} We recently reported that expression of B-crystallin, but not Hsp27, is directly linked to increases in oxidative metabolism in skeletal muscle after chronic nerve stimulation.¹⁴⁸ However, the physiological role of upregulation of Hsp27 expression, which precedes early differentiation of murine embryonic stem cells, remains to be established in myogenic lineages.¹⁴⁹

Much less is known about the regulatory mechanisms involved in B-crystallin–restricted expression in cardiac myocytes. B-Crystallin is abundantly expressed in early cardiac development beginning at embryonic day 8.5, suggesting a role either as a structural protein or as a molecular chaperone in myofiber stabilization.¹⁵⁰ Since Myo-D–like factors are absent in the heart, in vitro binding studies of cardiac nuclear extracts have implicated the transcriptional activities of an upstream stimulating factor at the E-box element and the serum response factor at a reverse CArG box in the B-crystallin promoter.¹⁵¹ So far, an in vivo developmental survey reveals that B-crystallin expression is unaffected in skeletal muscle of myf5 null mice or the heart of d-HAND null mice at embryonic day 9.0 (I.J. Benjamin, unpublished data, 1998).^{152 153}

Other Cytosolic/Nuclear Chaperones
Several other HSPs that exist in the cytosolic/nuclear compartment are of potential interest in cardiovascular biology. For example, the cytosolic 20-kDa protein, p20, is abundantly expressed in heart, skeletal, and smooth muscle and copurifies with the chaperones B-crystallin and Hsp27.^{154 155} Although p20 expression is induced by neither heat nor chemical stress, it contains the homologous C-terminal "-crystallin domain" shared by all members of the small MW HSPs.¹³⁸ In VSMCs, p20 is a substrate for both cAMP and cGMP protein kinases, suggesting a regulatory role to postulated functions in physiological maintenance of vascular tone and adaptation to vessel wall injury.¹⁵⁶

A fourth member of the small HSPs (besides Hsp27, B-crystallin, and p20), a myotonic dystrophy protein kinase–binding protein associates and increases the activity of dystrophy protein kinase and prevents its heat-induced denaturation in vitro.¹⁵⁷ Myotonic dystrophy protein kinase, unlike Hsp27 or B-crystallin, is upregulated in the skeletal muscle of patients with myotonic dystrophy, suggesting that this novel protein may be involved in the pathogenesis of this disease.¹⁵⁷

Members of the Hsp110 family exhibit chaperone and cytoprotective functions, although details about their relative expression in myocardial cells and regional distribution in the cardiovascular system await further characterization.¹⁵⁸ Additional Hsp110 family members include Hsp105, Apg-1, and Osp94.^{159 160 161} There is intense interest in identifying a mammalian homologue of yeast Hsp104, which, instead of preventing protein aggregation, seems to resolubilize insoluble protein aggregates.¹⁶²

Mitochondrial Hsp70 Chaperone System
All organisms possess ATP-dependent mechanisms for protein folding and assembly within organelles.^{11 13} Translocation of proteins across the mitochondrial membrane requires mitochondrial chaperone Hsp70 in the matrix, where folding into the native state is completed¹³ (see Figure 1).

Mitochondrial Chaperonin System
Besides Hsp70-like chaperones, mitochondrial chaperonins Hsp60 and Hsp10 constitute a separate system that provides a sequestered environment for folding a subset of proteins in vivo.¹⁶³ These 7-membered rings are arranged as cylindrical structures in which ATP-dependent protein folding occurs in their central cavity.¹⁶⁴ Evidence from in vitro studies suggests the Hsp70 chaperones and chaperonin systems function cooperatively in protein folding and assembly in eukaryotes (reviewed in Reference 13¹³ ).

Cytosolic Chaperonin System
TRiC chaperonin is considered the functional equivalent of chaperonin Hsp60/Hsp10 in the eukaryotic cytosol. The TRiC complex, which consists of either 8- or 9-membered double rings of 55 to 65 kDa subunits, is required for folding of actin and tubulin in vivo.¹⁶⁵ Chaperonin TRiC requires additional components, such as Hsp40, which stimulates the Hsc70 ATPase, for protein folding in the cytosol^{77 166} (see Figure 2). Available evidence suggests that TRiC chaperonin functions in the final stages of folding during translation of a limited number of polypeptide domains.¹³

Implications
Mitochondrial chaperones and chaperonins are only modestly induced by physiological stress in cardiomyocytes and the heart.¹⁶⁷ However, the location of mitochondrial Hsp70 chaperones and chaperonins at major sites of ROS production could serve to complement both enzymatic and nonenzymatic defense mechanisms to diminish oxidative injury and increase the rate of physiological recovery after ischemic injury.^{168 169} Whether overexpression of either mitochondrial Hsp75 chaperone or chaperonin can provide equivalent or superior protection against ischemic injury is presently unknown. Another important question concerns whether the overlapping functions of Hsp70 chaperones and Hsp60 or TRiC/Hsp40 chaperonin systems are coordinated for de novo protein folding and potential cytoprotection during the pathogenesis of heart disease.

	Molecular Chaperones in ER

Top Abstract Introduction Definitions and Nomenclature Stress Proteins Can Function... The Case for Molecular... Molecular Chaperones of the... Molecular Chaperones in ER Current Challenges and Future... Does Stress-Inducible Expression... Molecular Chaperones and Cell... Perspectives References

 
Glucose-Regulated Proteins
Analysis of ER chaperones may be of particular clinical interest, because the ER functions to degrade or repair proteins damaged after myocardial ischemia or after mutant proteins (eg, CFTR or thyroglobulin) fail to fold properly.^{11 170 171} Anoxia, glucose starvation, and calcium ionophores induce members of the Ca²⁺-binding glucose-regulated class of stress proteins, Grp170, Grp94, and Grp78/BiP.^{11 172} Variable changes in the expression of Grp78 protein have been reported after ischemia.^{173 174} Although "guilt by association" with cytosolic chaperones is the presumed role of chaperone Grp function in protein surveillance and quality control, more studies of their expression are needed in pathophysiological states associated with the expression, posttranslational glycosylation, and secretion of abnormal proteins via the ER-Golgi pathway.

Hsp47 Chaperones
The 47-kDa collagen-binding glycoprotein Hsp47 is a member of the serpin (serine protease inhibitor) superfamily and is highly induced by heat stress or pathophysiological states (eg, hepatic fibrosis) associated with increased collagen synthesis.¹⁷⁵ Hsp47 resides in the ER and contains the C-terminal Arg-Asp-Glu-Leu ER retention signal.¹⁷⁶ Hsp47 binds transiently to collagen types I to IV and avidly to denatured collagen substrates; thus, its role in procollagen processing and transport seems firmly established.¹⁷⁷ Future studies must now address the likely biological and clinical relevance of Hsp47 expression at the onset and progression of pathophysiological states, such as myocardial infarction, idiopathic and hypertrophic cardiomyopathies, and hypertension, in which myocardial fibrosis is prominently featured.¹⁷⁸

	Current Challenges and Future Directions

Top Abstract Introduction Definitions and Nomenclature Stress Proteins Can Function... The Case for Molecular... Molecular Chaperones of the... Molecular Chaperones in ER Current Challenges and Future... Does Stress-Inducible Expression... Molecular Chaperones and Cell... Perspectives References

 
Physiological recovery of the ischemic heart begins within minutes, but the rate of cellular ischemic repair, which may last for days to weeks, is critical for the reduction of subsequent cardiovascular morbidity and mortality. The idea that stress proteins can speed the physiological recovery of reversible myocardial injury is based on experimental evidence indicating that multiple proximate "signals" can activate the heat shock response and, thereby, evoke the endogenous protective mechanisms of Hsps. Major clinical events such as unstable angina, recurrent occlusion after thrombolytic therapy, and acute exacerbation of chronic angina are potential physiological inducers of cytoprotective stress proteins. The next logical step would be to consider the possibility that related members of the multigene stress protein family confer similar or additional functional benefits. Because ischemia and other physiological perturbations disrupt the normal structure-function relationships of intracellular proteins, future studies must establish whether molecular chaperones, either alone or in combination, alleviate ischemic damage by accelerating physiological recovery of the myocardial cell in the intact organism.

Experimental Models for Stress Protein Research
Transgenic models of Hsp70 overexpression (gain of function) and hsf1-deficient mice (loss of function), and their subsequent characterization, are beginning to illuminate their physiological roles in vivo.^{16 17 18 36} One exciting direction of such efforts could lead to integrated approaches into the physiological roles of entire systems or regulatory networks in genetically modified animal models of human diseases. However, the wealth of existing knowledge of physiological studies in animals larger than the mouse should not be disregarded. Studies to define the role of HSP expression in myocardial stunning using conscious animals could justify the development of transgenic rat and rabbit models. Potential limitations of such strategies include substantially greater costs from the longer gestation periods, longer time to reach sexual maturity, and smaller litter sizes of such larger species. However, investigators with expertise in molecular biology and molecular physiology undertaking collaborative projects increase the chances of success, while avoiding the duplication of efforts.

	Does Stress-Inducible Expression of HSP Genes Affect Infarct Size, Arrhythmogenesis, and Myocardial Remodeling After Acute Myocardial Infarction?

Top Abstract Introduction Definitions and Nomenclature Stress Proteins Can Function... The Case for Molecular... Molecular Chaperones of the... Molecular Chaperones in ER Current Challenges and Future... Does Stress-Inducible Expression... Molecular Chaperones and Cell... Perspectives References

 
Previous studies have demonstrated that pretreatment (24 hours) with heat stress attenuates free radical release in the isolated rat heart⁹⁵ and reduces the amount of arrhythmias, a major functional hallmark of ischemia/reperfusion injury (reviewed in Reference 92⁹² ). Together, these studies correlate potential interactions between these protective pathways but are inadequate to establish a cause and effect relationship. The development of an HSF1 gene knockout mouse model provides a powerful experimental approach to determine whether a deficiency in stress-inducible HSP synthesis, during physiological perturbations such as myocardial ischemia, affects the outcome of postinfarction injury and the repair mechanisms in the intact organism. Results of such studies can help establish causality, elucidate potential mechanisms by which HSP synthesis relates to myocardial ischemia, and evaluate the participation of stress proteins during early and late ischemic preconditioning. Timely characterization of several knockout models, currently in development in laboratories worldwide, should continue to foster fruitful collaborations among investigators.¹⁷⁹ Further progress should accelerate the flow of new knowledge into related areas such as postischemic reactive and reparative fibrosis,¹⁸⁰ postreperfusion inflammation,¹⁸¹ and myocardial stunning.^{89 182}

Stress Protein Expression and Mechanisms of Ischemic Preconditioning
Ischemic preconditioning is the most powerful experimental maneuver that reproducibly protects the heart against subsequent ischemic challenge.¹⁸³ However, controversy exists about the precise roles of stress proteins in this well-characterized phenomenon.¹⁸⁴ Several mechanisms involving protein kinase C, adenosine receptors, and their relationships to signal transduction pathways have been implicated in ischemic preconditioning.¹⁸⁵ Sufficient evidence indicates a lack of correlation between stress-inducible expression (eg, Hsp70) and early preconditioning, which is short-lived and lasts between 1 and 3 hours, depending on the model and species.¹⁸⁶

Is the Chaperone Family of Stress Proteins Unlikely to Have Physiological Relevance in Early Preconditioning?
In our opinion, studies in this area have either prematurely dismissed or paid inadequate attention to the potential importance of the small MW Hsps, such as B-crystallin and Hsp27. These chaperones seem likely to be candidates for the "first line of defense" against nonlethal stress. Whether oligomerization of small MW Hsps contributes to the mechanical stability or speculated role of the cytoskeleton in ischemic protection of the cardiac myocyte is presently unknown.^{187 188} Both B-crystallin and Hsp27 gene knockout models, currently in development, could directly address this hypothesis.

Similarly, studies are needed to address the correlation between late preconditioning and stress protein expression. Twenty-four hours after an initial ischemic stress, several studies have reported increases in Hsp60 and Hsp70 synthesis in rabbits,⁴¹ Hsp70 in pigs,¹⁸² and manganese-SOD in dogs^{189 190} and delayed ischemic tolerance or late preconditioning. Therefore, a fundamental question is whether a direct relationship exists between stress protein expression and late preconditioning.^{191 192 193} A more detailed assessment of the specific role of individual Hsp in cardioprotection is also required. Attempts to determine the mechanism of the cardioprotective ATP-sensitive potassium channel by use of inhibitors have found a lack of correlation with stress protein Hsp70 expression.¹⁹⁴ However, approaches using specific inhibitors are inadequate for establishing specificity, to any degree of certainty, beyond the proteins under investigation.¹⁹⁵

	Molecular Chaperones and Cell Death Pathways

Top Abstract Introduction Definitions and Nomenclature Stress Proteins Can Function... The Case for Molecular... Molecular Chaperones of the... Molecular Chaperones in ER Current Challenges and Future... Does Stress-Inducible Expression... Molecular Chaperones and Cell... Perspectives References

 
Stress proteins are ideal candidates to play key regulatory roles in cell survival and death pathways involving DNA damage and protein synthesis, repair, and degradation. Maneuvers that increase Hsp70 expression after heat shock, sodium butyrate exposure, and constitutive or regulated overexpression inhibit apoptosis in a variety of cell types.^{196 197 198} The proto-oncogene c-myc potentiates heat shock–induced apoptosis^{199 200} ; in contrast, Bcl-2 overexpression augments thermotolerance-induced cellular survival.²⁰¹ Tissue-specific expression of Hsp70-2 prevents apoptosis in certain mitotic cells through a mechanism involving cell cycle control.²⁰² Hsp70 chaperone function in regulating apoptosis may be at the level of signal transduction, as it has been implicated in the stress-activated kinase pathway.²⁰³

Recent studies in our laboratory using hsf1-deficient cultured cells have established the role of stress-inducible Hsps to render cells thermotolerant to heat-induced apoptosis.³⁶ The present study provides a genetic model to examine potential interdependent relationships between stress-inducible of Hsps and the mechanisms involved in cell survival and/or cell death pathways. Sublethal heat stress protects mitochondria against oxidative stress and prevents cell death by apoptosis.²⁰⁴ Given their strategic locations in all major organelles, it is tempting to speculate that multiple Hsps may combat oxidative stress/damage by refolding damaged repressors of the cell death pathway or preventing their degradation. Alternatively, repressing the release of suicide activators such as cytochrome c could occur through interactions with mitochondrial chaperones and chaperonins (Figure 1).

In addition, results of several recent studies have implicated the small MW Hsp25/27 in cell survival pathways involving cell differentiation and oxidative stress/damage. Previous studies have demonstrated that overexpression of Hsp25/27, like the antiapoptotic protein Bcl-2, increases the levels of the antioxidant glutathione and resistance to Fas/APO-1–mediated apoptosis, although whether this occurs directly remains unclear.²⁰⁵ Withdrawal of mouse embryonic stem cells from the cell cycle induces upregulation of Hsp25/27 mRNA, which is accompanied by decreases in phosphorylation and increases in oligomerization of Hsp25/27 protein.¹⁴⁹ Antisense reduction of Hsp25/27 reverses these changes through the prolongation of the cell cycle, reduction in glutathione levels, and acceleration toward apoptosis. Together, these provocative findings suggest that during proliferation and differentiation of myocardial cells, the Hsp25/27 chaperone, and others, can reduce oxidative stress/damage and prevent apoptosis through a novel redox-dependent mechanism.²⁰⁶

Does Stress-Inducible Expression of HSP Genes Affect the Natural History of Chronic Cardiovascular Diseases, Including Aging?
Numerous studies have correlated the induction of Hsp expression and pressure overload by aortic banding, acute hypertension, exposure to vasoactive agents or left ventricular hypertrophy, and growth factor expression in several cell types.^{207 208 209} Decreases in the expression of HSP genes and the DNA-binding activity of HSF1 are reported to occur during the aging process in the rodent myocardium.²¹⁰ There is increasing evidence suggesting that oxidative stress/damage may be a major causal factor in the aging process.²¹¹ The level of oxidative stress and the susceptibility of tissues to experimentally induced oxidative stress seem to increase during the aging process. Whether the increased amounts of molecular oxidative damage, observed during the aging process, are causally associated with a decreased activity of HSF1 and, by implication, Hsp gene expression is presently unknown. The availability of transgenic and gene knockout models will enable future studies to establish the role of stress-inducible heat shock gene expression during normal aging or physiological adaptation to disease-associated cardiac risk factor(s).

Molecular Chaperones in Cardiac Disease States Caused by Expression of Mutant Proteins
Elevated levels of misfolded or denatured proteins, as well as microinjection of abnormal proteins, are potent inducers of HSP gene expression.^{14 59} Recent studies indicating that the Hsc70 chaperone interacts indirectly with the CFTR harboring the common F508 folding mutation support this general notion of their biological role in human diseases.²⁰

From the perspective of chaperone biology, cardiac diseases that arise from mutations in genes encoding components of the contractile apparatus or ion channel proteins are essentially problems of abnormal proteins. Multiple mutations of sarcomeric proteins have been implicated in the pathogenesis of familial hypertrophic cardiomyopathy, including myosin heavy and light chains, troponin I and T subunits, myosin binding protein C, and tropomyosin (Reference 6⁶ and reviewed in Reference 7⁷ ). Whereas chaperone Hsp27 plays a role in actin polymerization and chaperonin TRiC is involved in actin and tubulin folding, the physiological role of chaperone and chaperonin systems in folding and assembly of sarcomeric structures, under normal conditions or in disease, remains a mystery. Conceivably, chaperones can influence either the repair or degradation of mutant sarcomeric proteins, which, ultimately, affect the structure-function relationships and phenotype of the disease.²¹² In vitro analyses are first needed to determine whether chaperone function can affect productive protein folding caused by the relevant mutations, which can be validated in appropriate animal models.^{18 213}

Molecular Chaperones in Vascular Biology
Numerous opportunities exist to dissect chaperone functions during the synthesis and secretion of biological active peptides and proteins, cellular proliferation, intracellular signaling, and cytoskeletal rearrangement. Results of such studies may identify the specific HSP protein targets and the specificity among the various cell types in promoting the vascular protective effects of estrogen.^{214 215} The essential roles of Hsp90 and cochaperones in steroid receptor biology suggest that HSP chaperones play a clinically significant role in the effects of hormonal replacement therapy in postmenopausal women.^{216 217} Epidemiological studies have found that the protective benefit against coronary heart disease in premenopausal women is abolished in the postmenopausal years.^{218 219 220} Potential protective actions of estrogen have been attributed to its antioxidative and vasoprotective properties, lowering of blood lipids and lipoproteins, and direct effects on the vessel wall.²²¹ It will be important to define whether stress-inducible Hsp expression in genetically modified mice plays a role in the vascular response to injury in male and female animals.²¹⁵

Molecular Chaperone and Immunological Diseases
In contrast to their well-established cytoprotective roles, certain stress proteins have been implicated in the pathogenesis of cardiovascular diseases. For example, elevated serum levels of antibodies against the bacterial homologue of mammalian Hsp60 have been demonstrated in patients with cardiomyopathy and diabetes, in asymptomatic individuals with carotid stenosis, and in atherosclerotic lesions in rabbits and humans (reviewed in Reference 222²²² ). One hypothesis is that autoimmune disease results from cross-reactivity of immunogenic peptides, which are derived from bacterial and mitochondrial chaperones and Hsp60 (chaperonin) and are recognized by activated / T lymphocytes.^{223 224} Humoral immune responses and seropositive markers against the Hsp70 family (especially ER Grp78 and Hsc70) of the protozoan parasite Trypanosoma cruzi have been implicated in the pathogenesis of Chagas' disease,^224A the most common cause of congestive heart failure in Latin America (see Table). Although these correlative studies have inherent limitations, future research to establish causality could open avenues to develop vaccines or other novel therapies for treatment and prevention.

Potential Therapeutic Applications of Molecular Chaperones
Strategies that could increase the rate of physiological recovery after postinfarction stunning and ventricular dysfunction remain important goals in the management of patients with acute myocardial infarction. Because maneuvers using either tissue or whole body hyperthermia are cumbersome and impractical in conscious humans, pharmacological strategies that increase stress protein expression for isothermal protection have potential merit against ischemic damage to the heart, kidney, and brain. Proteasome inhibitors, which transiently elevate the level of unfolded proteins inside cells, is one potential approach.²²⁵ Alternative approaches may involve the development of small molecules and peptides^{226 226A} that mimic the in vivo actions of chaperones with therapeutic benefits.

	Perspectives

Top Abstract Introduction Definitions and Nomenclature Stress Proteins Can Function... The Case for Molecular... Molecular Chaperones of the... Molecular Chaperones in ER Current Challenges and Future... Does Stress-Inducible Expression... Molecular Chaperones and Cell... Perspectives References

 
The role of stress proteins in cardioprotection has been acknowledged as one of the most important future directions of research in ischemic heart disease.²²⁷ Since the number of affected individuals is so large, a therapeutic intervention that contributes to a small change in post–myocardial infarction morbidity and mortality, for example, can have dramatic effects on overall clinical outcomes. Opportunities to address the physiological roles of cytoprotective chaperones in cardiac diseases need to be expanded to include their likely roles during chronic conditions (atherosclerotic, hypertension, diabetes, genetic disorders, and valvular heart disease) that converge through common pathways, resulting in heart failure and sudden death. Strategic alliances among research teams could forge new directions and accelerate progress in this promising area, which, ultimately, could succeed in exploiting endogenous pathways to enhance physiological health and to reduce physiological attrition associated with cardiovascular diseases.

	Selected Abbreviations and Acronyms

 

CFTR = cystic fibrosis transmembrane conductance regulator ER = endoplasmic reticulum ERK = extracellularly responsive kinase Grp = glucose-related protein HO = heme oxygenase Hsc = heat shock cognate HSF = heat shock transcription factor HSP = heat shock family of stress proteins Hsp = heat shock protein JNK = c-Jun N-terminal kinase MAPK = mitogen-activated protein kinase MAPKAP = MAPK-activated protein kinase MW = molecular weight ROS = reactive oxygen species SAPK = stress-activated protein kinase TRiC = TCP-1 ring complex VSMC = vascular smooth muscle cell

	Acknowledgments

 
Dr Benjamin was supported by the American Foundation for Medical Research, the National Institutes of Health, and an Established Investigator Award from the American Heart Association. We thank R. S. Williams, R. Meidell, A. Davis, P. Thomas, and R. Sohal for their critical comments regarding our manuscript.

Received February 4, 1998; accepted March 25, 1998.

	References

Top Abstract Introduction Definitions and Nomenclature Stress Proteins Can Function... The Case for Molecular... Molecular Chaperones of the... Molecular Chaperones in ER Current Challenges and Future... Does Stress-Inducible Expression... Molecular Chaperones and Cell... Perspectives References

 
1. Rannels DE, Chua B, Kao R, Morgan HE. Inhibition of protein degradation in the energy-poor heart. Adv Myocardiol. 1980;1:535–546.[Medline] [Order article via Infotrieve]

2. Westfall MV, Solaro RJ. Alterations in myofibrillar function and protein profiles after complete global ischemia in rat hearts. Circ Res. 1992;70:302–313.[Abstract/Free Full Text]

3. Yoshida Y, Shiga T, Imai S. Degradation of sarcoplasmic reticulum calcium-pumping ATPase in ischemic-reperfused myocardium: role of calcium-activated neutral protease. Basic Res Cardiol. 1990;85:495–507.[Medline] [Order article via Infotrieve]

4. Gao WD, Atar D, Liu Y, Perez NG, Murphy AM, Marban E. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res. 1997;80:393–399.

5. Tanigawa G, Jarcho JA, Kass S, Solomon SD, Vosberg HP, Seidman JG, Seidman CE. A molecular basis for familial hypertrophic cardiomyopathy: an alpha/beta cardiac myosin heavy chain hybrid gene. Cell. 1990;62:991–998.[Medline] [Order article via Infotrieve]

6. Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE, Seidman JG. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell. 1990;62:999–1006.[Medline] [Order article via Infotrieve]

7. Vikstrom KL, Leinwand LA. Contractile protein mutations and heart disease. Curr Opin Cell Biol. 1996;8:97–105.[Medline] [Order article via Infotrieve]

8. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995;80:795–803.[Medline] [Order article via Infotrieve]

9. Keating MT. The long QT syndrome: a review of recent molecular genetic and physiologic discoveries. Medicine (Baltimore). 1996;75:1–5.[Medline] [Order article via Infotrieve]

10. Lindquist S, Craig EA. The heat-shock proteins. Annu Rev Genet. 1988;22:631–677.[Medline] [Order article via Infotrieve]

11. Gething MJ, Sambrook J. Protein folding in the cell. Nature. 1992;355:33–45.[Medline] [Order article via Infotrieve]

12. Ellis RJ, Hemmingsen SM. Molecular chaperones: proteins essential for the biogenesis of some macromolecular structures. Trends Biochem Sci. 1989;14:339–342.[Medline] [Order article via Infotrieve]

13. Hartl F. Molecular chaperones in cellular protein folding. Nature. 1996;381:571–579.[Medline] [Order article via Infotrieve]

14. Pelham HR. Speculations on the functions of the major heat shock and glucose-regulated proteins. Cell. 1986;46:959–961.[Medline] [Order article via Infotrieve]

15. Hightower LE. Heat shock, stress proteins, chaperones, and proteotoxicity. Cell. 1991;66:191–197.[Medline] [Order article via Infotrieve]

16. Plumier JC, Ross BM, Currie RW, Angelidis CE, Kazlaris H, Kollias G, Pagoulatos GN. Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery. J Clin Invest. 1995;95:1854–1860.

17. Marber MS, Mestril R, Chi SH, Sayen MR, Yellon DM, Dillmann WH. Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J Clin Invest. 1995;95:1446–1456.

18. Radford NB, Fina M, Benjamin IJ, Moreadith RW, Graves KH, Zhao P, Gavva S, Wiethoff A, Sherry AD, Malloy CR, Williams RS. Cardioprotective effects of 70-kDa heat shock protein transgenic mice. Proc Natl Acad Sci U S A.. 1996;93:2339–2342.[Abstract/Free Full Text]

19. Thomas PJ, Qu BH, Pedersen PL. Defective protein folding as a basis of human disease. Trends Biochem Sci. 1995;20:456–459.[Medline] [Order article via Infotrieve]

20. Strickland E, Qu BH, Millen L, Thomas PJ. The molecular chaperone Hsc70 assists the in vitro folding of the N-terminal nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator. J Biol Chem. 1997;272:25421–25424.[Abstract/Free Full Text]

21. Ritossa F. Discovery of the heat shock response. Cell Stress Chaperones. 1996;1:97–98.[Medline] [Order article via Infotrieve]

22. Tissieres A, Mitchell HK, Tracy UM. Protein synthesis in salivary glands of Drosophila melanogaster: relation to chromosome puffs. J Mol Biol. 1974;84:389–398.[Medline] [Order article via Infotrieve]

23. Hightower LE, Hendershot LM. Molecular chaperones and the heat shock response at Cold Spring Harbor. Cell Stress Chaperones. 1997;2:1–11.[Medline] [Order article via Infotrieve]

24. Jennings RB, Ganote CE, Reimer KA. Ischemic tissue injury. Am J Pathol. 1975;81:179–198.[Abstract]

25. Welch WJ. How cells respond to stress. Sci Am. 1993;268:56–64.

26. Welch WJ, Kang HS, Beckmann RP, Mizzen LA. Response of mammalian cells to metabolic stress: changes in cell physiology and structure/function of stress proteins. Curr Top Microbiol Immunol. 1991;167:31–55.[Medline] [Order article via Infotrieve]

27. Laszlo A. The thermoresistant state: protection from initial damage or better repair? Exp Cell Res.. 1992;202:519–531.[Medline] [Order article via Infotrieve]

28. Neely JR, Grotyohann LW. Role of glycolytic products in damage to ischemic myocardium: dissociation of adenosine triphosphate levels and recovery of function of reperfused ischemic hearts. Circ Res. 1984;55:816–824.[Abstract/Free Full Text]

29. Patriarca EJ, Maresca B. Acquired thermotolerance following heat shock protein synthesis prevents impairment of mitochondrial ATPase activity at elevated temperatures in Saccharomyces cerevisiae. Exp Cell Res. 1990;190:57–64.[Medline] [Order article via Infotrieve]

30. Patriarca EJ, Kobayashi GS, Maresca B. Mitochondrial activity and heat-shock response during morphogenesis in the pathogenic fungus Histoplasma capsulatum. Biochem Cell Biol. 1992;70:207–214.[Medline] [Order article via Infotrieve]

31. Panniers R, Stewart EB, Merrick WC, Henshaw EC. Mechanism of inhibition of polypeptide chain initiation in heat-shocked Ehrlich cells involves reduction of eukaryotic initiation factor 4F activity. J Biol Chem. 1985;260:9648–9653.[Abstract/Free Full Text]

32. Scorsone KA, Panniers R, Rowlands AG, Henshaw EC. Phosphorylation of eukaryotic initiation factor 2 during physiological stresses which affect protein synthesis. J Biol Chem. 1987;262:14538–14543.[Abstract/Free Full Text]

33. Zapata JM, Maroto FG, Sierra JM. Inactivation of mRNA cap-binding protein complex in Drosophila melanogaster embryos under heat shock. J Biol Chem. 1991;266:16007–16014.[Abstract/Free Full Text]

34. Theodorakis NG, Morimoto RI. Posttranscriptional regulation of hsp70 expression in human cells: effects of heat shock, inhibition of protein synthesis, and adenovirus infection on translation and mRNA stability. Mol Cell Biol. 1987;7:4357–4368.[Abstract/Free Full Text]

35. Arrigo AP, Suhan JP, Welch WJ. Dynamic changes in the structure and intracellular locale of the mammalian low-molecular-weight heat shock protein. Mol Cell Biol. 1988;8:5059–5071.[Abstract/Free Full Text]

36. McMillan DR, Xiao X, Shao L, Graves K, Benjamin IB. Targeted disruption of heat shock transcription factor 1 abolishes thermotolerance and protection against heat-induced apoptosis. J Biol Chem. 1998;273:7523–7528.[Abstract/Free Full Text]

37. Hargrove JL, Schmidt FH. The role of mRNA and protein stability in gene expression. FASEB J. 1989;3:2360–2370.[Abstract]

38. Yost HJ, Lindquist S. Heat shock proteins affect RNA processing during the heat shock response of Saccharomyces cerevisiae. Mol Cell Biol. 1991;11:1062–1068.[Abstract/Free Full Text]

39. Dellavalle RP, Petersen R, Lindquist S. Preferential deadenylation of Hsp70 mRNA plays a key role in regulating Hsp70 expression in Drosophila melanogaster. Mol Cell Biol. 1994;14:3646–3659.[Abstract/Free Full Text]

40. Currie RW, Karmazyn M, Kloc M, Mailer K. Heat-shock response is associated with enhanced postischemic ventricular recovery. Circ Res. 1988;63:543–549.[Abstract/Free Full Text]

41. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation. 1993;88:1264–1272.[Abstract/Free Full Text]

42. Morimoto RI, Tissieres A, Georgopoulos C. Progress and perspectives on the biology of heat shock proteins and molecular chaperones. In: Morimoto RI, Tissieres A, Georgopoulos C, eds. The Biology of Heat Shock Proteins and Molecular Chaperones. Cold Spring Harbor, NY: Cold Spring Harbor Press; 1994.

43. Morimoto RI. Cells in stress: transcriptional activation of heat shock genes. Science. 1993;259:1409–1410.[Free Full Text]

44. Wu C. Heat shock transcription factors: structure and regulation. Ann Rev Cell Dev Biol. 1995;11:441–469.[Medline] [Order article via Infotrieve]

45. Sorger PK, Pelham HR. Yeast heat shock factor is an essential DNA-binding protein that exhibits temperature-dependent phosphorylation. Cell. 1988;54:855–864.[Medline] [Order article via Infotrieve]

46. Jedlicka P, Mortin MA, Wu C. Multiple functions of Drosophila heat shock transcription factor in vivo. EMBO J. 1997;16:2452–2462.[Medline] [Order article via Infotrieve]

47. Nakai A, Kawazoe Y, Tanabe M, Nagata K, Morimoto RI. The DNA-binding properties of two heat shock factors, HSF1 and HSF3, are induced in the avian erythroblast cell line HD6. Mol Cell Biol. 1995;15:5268–5278.[Abstract/Free Full Text]

48. Scharf KD, Rose S, Zott W, Schoffl F, Nover L, Schoff F. Three tomato genes code for heat stress transcription factors with a region of remarkable homology to the DNA-binding domain of the yeast HSF [published erratum appears in EMBO J. 1991;10:1026]. EMBO J. 1990;9:4495–4501.

49. Sarge KD, Zimarino V, Holm K, Wu C, Morimoto RI. Cloning and characterization of two mouse heat shock factors with distinct inducible and constitutive DNA-binding ability. Genes Dev. 1991;5:1902–1911.[Abstract/Free Full Text]

50. Schuetz TJ, Gallo GJ, Sheldon L, Tempst P, Kingston RE. Isolation of a cDNA for HSF2: evidence for two heat shock factor genes in humans. Proc Natl Acad Sci U S A.. 1991;88:6911–6915.[Abstract/Free Full Text]

51. Rallu M, Loones M, Lallemand Y, Morimoto R, Morange M, Mezger V. Function and regulation of heat shock factor 2 during mouse embryogenesis. Proc Natl Acad Sci U S A.. 1997;94:2392–2397.[Abstract/Free Full Text]

52. Knauf U, Newton EM, Kyriakis J, Kingston RE. Repression of human heat shock factor 1 activity at control temperature by phosphorylation. Genes Dev. 1996;10:2782–2793.[Abstract/Free Full Text]

53. Kim J, Nueda A, Meng YH, Dynan WS, Mivechi NF. Analysis of the phosphorylation of human heat shock transcription factor-1 by MAP kinase family members. J Cell Biochem. 1997;67:43–54.[Medline] [Order article via Infotrieve]

54. Abravaya K, Myers MP, Murphy SP, Morimoto RI. The human heat shock protein hsp70 interacts with HSF, the transcription factor that regulates heat shock gene expression. Genes Dev. 1992;6:1153–1164.[Abstract/Free Full Text]

55. Rabindran S, Wisniewski J, Li L, Li G, Wu C. Interaction between heat shock factor 70 and hsp70 is insufficient to suppress induction of DNA-binding activity in vivo. Mol Cell Biol. 1994;14:6552–6560.[Abstract/Free Full Text]

56. Lis J, Wu C. Protein traffic on the heat shock promoter: parking, stalling, and trucking along. Cell. 1993;74:1–4.[Medline] [Order article via Infotrieve]

57. Benjamin IJ, Kroger B, Williams RS. Activation of the heat shock transcription factor by hypoxia in mammalian cells. Proc Natl Acad Sci U S A.. 1990;87:6263–6267.[Abstract/Free Full Text]

58. Benjamin IJ, Horie S, Greenberg ML, Alpern RJ, Williams RS. Induction of stress proteins in cultured myogenic cells: molecular signals for the activation of heat shock transcription factor during ischemia. J Clin Invest. 1992;89:1685–1689.

59. Ananthan J, Goldberg AL, Voellmy R. Abnormal proteins serve as eukaryotic stress signals and trigger the activation of heat shock genes. Science. 1986;232:522–524.[Abstract/Free Full Text]

60. Zhu W, Roma P, Pirillo A, Pellegatta F, Catapano AL. Human endothelial cells exposed to oxidized LDL express hsp70 only when proliferating. Arterioscler Thromb Vasc Biol. 1996;16:1104–1111.[Abstract/Free Full Text]

61. Xu Q, Hu Y, Kleindienst R, Wick G. Nitric oxide induces heat-shock protein 70 expression in vascular smooth muscle cells via activation of heat shock factor 1. J Clin Invest. 1997;100:1089–1097.[Medline] [Order article via Infotrieve]

62. Xiao H, Lis JT. Germline transformation used to define key features of heat-shock response elements. Science. 1988;239:1139–1142.[Abstract/Free Full Text]

63. Amin J, Ananthan J, Voellmy R. Key features of heat shock regulatory elements. Mol Cell Biol. 1988;8:3761–3769.[Abstract/Free Full Text]

64. Ciocca DR, Fuqua SA, Lock-Lim S, Toft DO, Welch WJ, McGuire WL. Response of human breast cancer cells to heat shock and chemotherapeutic drugs. Cancer Res. 1992;52:3648–3654.[Abstract/Free Full Text]

65. Mehta HB, Popovich BK, Dillmann WH. Ischemia induces changes in the level of mRNAs coding for stress protein 71 and creatine kinase M. Circ Res. 1988;63:512–517.[Abstract/Free Full Text]

66. Knowlton AA, Brecher P, Apstein CS. Rapid expression of heat shock protein in the rabbit after brief cardiac ischemia. J Clin Invest. 1991;87:139–147.

67. Yellon DM, Alkhulaifi AM, Browne EE, Pugsley WB. Ischaemic preconditioning limits infarct size in the rat heart. Cardiovasc Res. 1992;26:983–987.[Abstract/Free Full Text]

68. Donnelly TJ, Sievers RE, Vissern FL, Welch WJ, Wolfe CL. Heat shock protein induction in rat hearts: a role for improved myocardial salvage after ischemia and reperfusion? Circulation. 1992;85:769–778.[Abstract/Free Full Text]

69. Currie RW, Tanguay RM, Kingma JG Jr. Heat-shock response and limitation of tissue necrosis during occlusion/reperfusion in rabbit hearts [see comments]. Circulation. 1993;87:963–971.[Abstract/Free Full Text]

70. Hutter MM, Sievers RE, Barbosa V, Wolfe CL. Heat-shock protein induction in rat hearts: a direct correlation between the amount of heat-shock protein induced and the degree of myocardial protection. Circulation. 1994;89:355–360.[Abstract/Free Full Text]

71. Williams RS, Thomas JA, Fina M, German Z, Benjamin IJ. Human heat shock protein 70 (hsp70) protects murine cells from injury during metabolic stress. J Clin Invest. 1993;92:503–508.

72. Mestril R, Chi SH, Sayen MR, O'Reilly K, Dillmann WH. Expression of inducible stress protein 70 in rat heart myogenic cells confers protection against simulated ischemia-induced injury. J Clin Invest. 1994;93:759–767.

73. Hutter JJ, Mestril R, Tam EK, Sievers RE, Dillmann WH, Wolfe CL. Overexpression of heat shock protein 72 in transgenic mice decreases infarct size in vivo. Circulation. 1996;94:1408–1411.[Abstract/Free Full Text]

74. Martin JL, Mestril R, Hilal-Dandan R, Brunton LL, Dillmann WH. Small heat shock proteins and protection against ischemic injury in cardiac myocytes. Circulation. 1997;96:4343–4348.[Abstract/Free Full Text]

75. Hightower LE, Sadis SE, Takenaka IM. Interactions of vertebrate hsc70 and hsp70 with unfolded proteins and peptides. In: Morimoto RI, Tissieres A, Georgopoulos C, eds. The Biology of Heat Shock Proteins and Molecular Chaperones. Cold Spring Harbor, NY: Cold Spring Harbor Press; 1994.

76. Ellis J. Proteins as molecular chaperones. Nature. 1987;328:378–379.[Medline] [Order article via Infotrieve]

77. Freeman BC, Myers MP, Schumacher R, Morimoto RI. Identification of a regulatory motif in Hsp70 that affects ATPase activity, substrate binding and interaction with HDJ-1. EMBO J. 1995;14:2281–2292.[Medline] [Order article via Infotrieve]

78. Chiang HL, Terlecky SR, Plant CP, Dice JF. A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins. Science. 1989;246:382–385.[Abstract/Free Full Text]

79. Tiefenbrunn AJ, Sobel BE. Timing of coronary recanalization: paradigms, paradoxes, and pertinence. Circulation. 1992;85:2311–2315.[Free Full Text]

80. Rogers WJ, Bowlby LJ, Chandra NC, French WJ, Gore JM, Lambrew CT, Rubison RM, Tiefenbrunn AJ, Weaver WD. Treatment of myocardial infarction in the United States (1990 to 1993): observations from the National Registry of Myocardial Infarction. Circulation. 1994;90:2103–2114.[Abstract/Free Full Text]

81. Jennings RB, Hawkins HK, Lowe JE, Hill ML, Klotman S, Reimer KA. Relation between high energy phosphate and lethal injury in myocardial ischemia in the dog. Am J Pathol. 1978;92:187–214.[Abstract]

82. Liu X, Engelman RM, Moraru II, Rousou JA, Flack JE III, Deaton DW, Maulik N, Das DK. Heat shock: a new approach for myocardial preservation in cardiac surgery. Circulation. 1992;86(suppl II):II-358–II-363.

83. Hearse DJ. Reperfusion of the ischemic myocardium. J Mol Cell Cardiol. 1977;9:605–616.[Medline] [Order article via Infotrieve]

84. Sohal RS, Agarwal A, Agarwal S, Orr WC. Simultaneous overexpression of copper- and zinc-containing superoxide dismutase and catalase retards age-related oxidative damage and increases metabolic potential in Drosophila melanogaster. J Biol Chem. 1995;270:15671–15674.[Abstract/Free Full Text]

85. Chan PH, Epstein CJ, Li Y, Huang TT, Carlson E, Kinouchi H, Yang G, Kamii H, Mikawa S, Kondo T, et al. Transgenic mice and knockout mutants in the study of oxidative stress in brain injury. J Neurotrauma. 1995;12:815–824.[Medline] [Order article via Infotrieve]

86. Kondo T, Sharp FR, Honkaniemi J, Mikawa S, Epstein CJ, Chan PH. DNA fragmentation and prolonged expression of c-fos, c-jun, and hsp70 in kainic acid-induced neuronal cell death in transgenic mice overexpressing human CuZn-superoxide dismutase. J Cereb Blood Flow Metab. 1997;17:241–256.[Medline] [Order article via Infotrieve]

87. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982;66:1146–1149.[Abstract/Free Full Text]

88. Bolli R. Oxygen-derived free radicals and myocardial reperfusion injury: an overview. Cardiovasc Drugs Ther. 1991;2:249–268.

89. Bolli R. Myocardial "stunning" in man. Circulation. 1992;86:1671–1691.[Free Full Text]

90. Marban E. Myocardial stunning and hibernation: the physiology behind the colloquialisms. Circulation. 1991;83:681–688.[Free Full Text]

91. Tanaka M, Richard VJ, Murry CE, Jennings RB, Reimer KA. Superoxide dismutase plus catalase therapy delays neither cell death nor the loss of the TTC reaction in experimental myocardial infarction in dogs. J Mol Cell Cardiol. 1993;25:367–378.[Medline] [Order article via Infotrieve]

92. Jeroudi MO, Hartley CJ, Bolli R. Myocardial reperfusion injury: role of oxygen radicals and potential therapy with antioxidants. Am J Cardiol. 1994;73:2B–7B.[Medline] [Order article via Infotrieve]

93. Pryor WA. Free radicals in autoxidation and in aging. In: Armstrong D, Sohal RS, Cutler RG, Slater TF, eds. Free Radicals in Molecular Biology, Aging, and Disease. New York, NY: Raven Press Publishers; 1984:13–41.

94. Karmazyn M, Mailer K, Currie RW. Acquisition and decay of heat-shock-enhanced postischemic ventricular recovery. Am J Physiol. 1990;259:H424–H431.[Abstract/Free Full Text]

95. Mocanu MM, Steare SE, Evans MC, Nugent JH, Yellon DM. Heat stress attenuates free radical release in the isolated perfused rat heart. Free Radic Biol Med. 1993;15:459–463.[Medline] [Order article via Infotrieve]

96. Tavaria M, Gabriele T, Kola I, Anderson RL. A hitchhiker's guide to the human Hsp70 family. Cell Stress Chaperones. 1996;1:23–28.[Medline] [Order article via Infotrieve]

97. Beckmann R, Mizzen L, Welch W. Interaction of Hsp 70 with newly synthesized proteins: implications for protein folding and assembly. Science. 1990;248:850–854.[Abstract/Free Full Text]

98. Flynn G, Pohl J, Flocco M, Rothman J. Peptide-binding specificity of the molecular chaperone BiP. Nature. 1991;353:726–730.[Medline] [Order article via Infotrieve]

99. Blond-Elguindi S, Cwirla SE, Dower WJ, Lipshutz RJ, Sprang SR, Sambrook JF, Gething MJ. Affinity panning of a library of peptides displayed on bacteriophages reveals the binding specificity of BiP. Cell. 1993;75:717–728.[Medline] [Order article via Infotrieve]

100. Flaherty KM, McKay DB, Kabsch W, Holmes KC. Similarity of the three-dimensional structures of actin and the ATPase fragment of a 70-kDa heat shock cognate protein. Proc Natl Acad Sci U S A.. 1991;88:5041–5045.[Abstract/Free Full Text]

101. Feder JH, Rossi JM, Solomon J, Solomon N, Lindquist S. The consequences of expressing hsp70 in Drosophila cells at normal temperatures. Genes Dev. 1992;6:1402–1413.[Abstract/Free Full Text]

102. James P, Pfund C, Craig EA. Functional specificity among Hsp70 molecular chaperones. Science. 1997;275:387–389.[Abstract/Free Full Text]

103. Lai B, Chin N, Stanek A, Keh W, Lanks K. Quantitation and intracellular localization of the 85K heat shock protein by using monoclonal and polyclonal antibodies. Mol Cell Biol. 1984;4:2802–2810.[Abstract/Free Full Text]

104. Denis M, Gustafsson J. The Mr approximately 90,000 heat shock protein: an important modulator of ligand and DNA-binding properties of the glucocorticoid receptor. Cancer Res. 1989;49:2275s–2281s.[Abstract/Free Full Text]

105. Sabbah M, Radanyi C, Redeuilh G, Balieu E. The 90 kDA heat-shock protein (hsp90) modulates the binding of the oestrogen receptor to its cognate DNA. Biochem J. 1996;314:205–213.

106. Pratt W. The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor. J Biol Chem. 1993;268:21455–21458.[Free Full Text]

107. Borkovich KA, Farrelly FW, Finkelstein DB, Taulien J, Lindquist S. hsp82 is an essential protein that is required in higher concentrations for growth of cells at higher temperatures. Mol Cell Biol. 1989;9:3919–3930.[Abstract/Free Full Text]

108. Cruse I, Maines MD. Evidence suggesting that the two forms of heme oxygenase are products of different genes. J Biol Chem. 1988;263:3348–3353.[Abstract/Free Full Text]

109. Ewing JF, Maines MD. Rapid induction of heme oxygenase 1 mRNA and protein by hyperthermia in rat brain: heme oxygenase 2 is not a heat shock protein. Proc Natl Acad Sci U S A.. 1991;88:5364–5368.[Abstract/Free Full Text]

110. McCoubrey WK Jr, Huang TJ, Maines MD. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem. 1997;247:725–732.[Medline] [Order article via Infotrieve]

111. Abraham NG, Pinto A, Levere RD, Mullane K. Identification of heme oxygenase and cytochrome P-450 in the rabbit heart. J Mol Cell Cardiol. 1987;19:73–81.[Medline] [Order article via Infotrieve]

112. Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 1988;2:2557–2568.[Abstract]

113. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 1992;258:1898–1902.[Abstract/Free Full Text]

114. Christodoulides N, Durante W, Kroll MH, Schafer AI. Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation. 1995;91:2306–2309.[Abstract/Free Full Text]

115. Wagner CT, Durante W, Christodoulides N, Hellums JD, Schafer AI. Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J Clin Invest. 1997;100:589–596.[Medline] [Order article via Infotrieve]

116. Durante W, Kroll MH, Christodoulides N, Peyton KJ, Schafer AI. Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res. 1997;80:557–564.[Abstract/Free Full Text]

117. Ishizaka N, Griendling KK. Heme oxygenase-1 is regulated by angiotensin II in rat vascular smooth muscle cells. Hypertension. 1997;29:790–795.[Abstract/Free Full Text]

118. Ishizaka N, de Leon H, Laursen JB, Fukui T, Wilcox JN, De Keulenaer G, Griendling KK, Alexander RW. Angiotensin II–induced hypertension increases heme oxygenase-1 expression in rat aorta. Circulation. 1997;96:1923–1929.[Abstract/Free Full Text]

119. Shibahara S, Muller RM, Taguchi H. Transcriptional control of rat heme oxygenase by heat shock. J Biol Chem. 1987;262:12889–12892.[Abstract/Free Full Text]

120. Muller RM, Taguchi H, Shibahara S. Nucleotide sequence and organization of the rat heme oxygenase gene. J Biol Chem. 1987;262:6795–6802.[Abstract/Free Full Text]

121. Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL, Choi AM. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem. 1997;272:5375–5381.[Abstract/Free Full Text]

122. Guillemin K, Krasnow MA. The hypoxic response: huffing and HIFing. Cell. 1997;89:9–12.[Medline] [Order article via Infotrieve]

123. Lee PJ, Alam J, Wiegand GW, Choi AM. Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. Proc Natl Acad Sci U S A.. 1996;93:10393–10398.[Abstract/Free Full Text]

124. Motterlini R, Foresti R, Intaglietta M, Winslow RM. NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol. 1996;270:H107–H114.[Abstract/Free Full Text]

125. Wong HR, Wispe JR. The stress response and the lung. Am J Physiol. 1997;273:L1–L9.[Abstract/Free Full Text]

126. Miron T, Vancompernolle K, Vandekerckhove J, Wilchek M, Geiger B. A 25-kD inhibitor of actin polymerization is a low molecular mass heat shock protein. J Cell Biol. 1991;114:255–261.[Abstract/Free Full Text]

127. Gaestel M, Schroder W, Benndorf R, Lippmann C, Buchner K, Hucho F, Erdmann VA, Bielka H. Identification of the phosphorylation sites of the murine small heat shock protein hsp25. J Biol Chem. 1991;266:14721–14724.[Abstract/Free Full Text]

128. Landry J, Lambert H, Zhou M, Lavoie JN, Hickey E, Weber LA, Anderson CW. Human HSP27 is phosphorylated at serines 78 and 82 by heat shock and mitogen-activated kinases that recognize the same amino acid motif as S6 kinase II. J Biol Chem. 1992;267:794–803.[Abstract/Free Full Text]

129. Huot J, Houle F, Spitz DR, Landry J. HSP27 phosphorylation-mediated resistance against actin fragmentation and cell death induced by oxidative stress. Cancer Res. 1996;56:273–279.[Abstract/Free Full Text]

130. Kyriakis JM, Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem. 1996;271:24313–24316.[Free Full Text]

131. Bogoyevitch MA, Gillespie-Brown J, Ketterman AJ, Fuller SJ, Ben-Levy R, Ashworth A, Marshall CJ, Sugden PH. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart: p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res. 1996;79:162–173.[Abstract/Free Full Text]

132. Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamarazes A, Zamanillo D, Hunt T, Nebreda AR. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of heat shock proteins. Cell. 1994;78:1027–1037.[Medline] [Order article via Infotrieve]

133. Rousseau S, Houle F, Landry J, Huot J. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene. 1997;15:2169–2177.[Medline] [Order article via Infotrieve]

134. Huot J, Houle F, Marceau F, Landry J. Oxidative stress–induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ Res. 1997;80:383–392.[Abstract/Free Full Text]

135. Lutsch G, Vetter R, Offhauss U, Wieske M, Grone HJ, Klemenz R, Schimke I, Stahl J, Benndorf R. Abundance and location of the small heat shock proteins HSP25 and alphaB-crystallin in rat and human heart. Circulation. 1997;96:3466–3476.[Abstract/Free Full Text]

136. Ingolia TD, Craig EA. Four small Drosophila heat shock proteins are related to each other and to mammalian alpha-crystallin. Proc Natl Acad Sci U S A.. 1982;79:2360–2364.[Abstract/Free Full Text]

137. Klemenz R, Frohli E, Steiger RH, Schafer R, Aoyama A. Alpha B-crystallin is a small heat shock protein. Proc Natl Acad Sci U S A.. 1991;88:3652–3656.[Abstract/Free Full Text]

138. de Jong WW, Leunissen JA, Voorter CE. Evolution of the alpha-crystallin/small heat-shock protein family. Mol Biol Evol. 1993;10:103–126.[Abstract]

139. Jakob U, Gaestel M, Engel K, Buchner J. Small heat shock proteins are molecular chaperones. J Biol Chem. 1993;268:1517–1520.[Abstract/Free Full Text]

140. Kato K, Shinohara H, Kurobe N, Inaguma Y, Shimizu K, Ohshima K. Tissue distribution and developmental profiles of immunoreactive alpha B crystallin in the rat determined with a sensitive immunoassay system. Biochim Biophys Acta. 1991;1074:201–208.[Medline] [Order article via Infotrieve]

141. Leach IH, Tsang ML, Church RJ, Lowe J. Alpha-B crystallin in the normal human myocardium and cardiac conducting system. J Pathol. 1994;173:255–260.[Medline] [Order article via Infotrieve]

142. Bennardini F, Wrzosek A, Chiesi M. B-Crystallin in cardiac tissue: association with actin and desmin filaments. Circ Res. 1992;71:288–294.[Abstract/Free Full Text]

143. Merck KB, Groenen PJ, Voorter CE, de Haard-Hoekman WA, Horwitz J, Bloemendal H, de Jong WW. Structural and functional similarities of bovine alpha-crystallin and mouse small heat-shock protein: a family of chaperones. J Biol Chem. 1993;268:1046–1052.[Abstract/Free Full Text]

144. Longoni S, James P, Chiesi M. Cardiac alpha-crystallin, I: isolation and identification [corrected and republished with original paging, article originally printed in Mol Cell Biochem.. 1990;97:113–20]. Mol Cell Biochem. 1990;99:113–120.

145. Haynes JI II, Duncan MK, Piatigorsky J. Spatial and temporal activity of the alpha B-crystallin/small heat shock protein gene promoter in transgenic mice. Dev Dyn. 1996;207:75–88.[Medline] [Order article via Infotrieve]

146. Gopal-Srivastava R, Piatigorsky J. The murine alpha B-crystallin/small heat shock protein enhancer: identification of alpha BE-1, alpha BE-2, alpha BE-3, and MRF control elements. Mol Cell Biol. 1993;13:7144–7152.[Abstract/Free Full Text]

147. Olson EN. Regulation of muscle transcription by the MyoD family: the heart of the matter. Circ Res. 1993;72:1–6.[Abstract/Free Full Text]

148. Neufer PD, Benjamin IJ. Differential expression of alpha B-crystallin and hsp27 in skeletal muscle during continuous contractile activity: relationship to myogenic regulatory factors. J Biol Chem. 1996;271:24089–24095.[Abstract/Free Full Text]

149. Mehlen P, Mehlen A, Godet J, Arrigo AP. Hsp27 as a switch between differentiation and apoptosis in murine embryonic stem cells. J Biol Chem. 1997;272:31657–31665.[Abstract/Free Full Text]

150. Benjamin IJ, Shelton J, Garry DJ, Richardson JA. Temporospatial expression of the small HSP/alpha B-crystallin in cardiac and skeletal muscle during mouse development. Dev Dyn. 1997;208:75–84.[Medline] [Order article via Infotrieve]

151. Gopal-Srivastava R, Hapnes JI II, Piatigorsky J. Regulation of the murine aB-crystallin/small heat shock protein gene in cardiac muscle. Mol Cell Biol. 1995;15:7081–7090.[Abstract/Free Full Text]

152. Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH, Jaenisch R. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell. 1993;75:1351–1359.[Medline] [Order article via Infotrieve]

153. Srivastava D, Cserjesi P, Olson EN. A subclass of bHLH proteins required for cardiac morphogenesis. Science. 1995;270:1995–1999.[Abstract/Free Full Text]

154. Kato K, Goto S, Inaguma Y, Hasegawa K, Morishita K, Asano T. Purification and characterization of a 20-kDa protein that is highly homologous to alpha B-crystallin. J Biol Chem. 1994;269:15302–15309.[Abstract/Free Full Text]

155. Caspers GJ, Leunissen JA, de Jong WW. The expanding small heat-shock protein family, and structure predictions of the conserved "alpha-crystallin domain." J Mol Evol. 1995;40:238–248.[Medline] [Order article via Infotrieve]

156. Beall AC, Kato K, Goldenring JR, Rasmussen H, Brophy CM. Cyclic nucleotide-dependent vasorelaxation is associated with the phosphorylation of a small heat shock-related protein. J Biol Chem. 1997;272:11283–11287.[Abstract/Free Full Text]

157. Suzuki A, Sugiyama Y, Hayashi Y, Nyu-i N, Yoshida M, Nonaka I, Ishiura S, Arahata K, Ohno S. MKBP, a novel member of the small heat shock protein family, binds and activates the myotonic dystrophy protein kinase. J Cell Biol. 1998;140:1113–1124.[Abstract/Free Full Text]

158. Lee-Yoon D, Easton D, Murawski M, Burd R, Subjeck JR. Identification of a major subfamily of large hsp70-like proteins through the cloning of the mammalian 110-kDa heat shock protein. J Biol Chem. 1995;270:15725–15733.[Abstract/Free Full Text]

159. Yasuda K, Nakai A, Hatayama T, Nagata K. Cloning and expression of murine high molecular mass heat shock proteins, HSP105. J Biol Chem. 1995;270:29718–29723.[Abstract/Free Full Text]

160. Kaneko Y, Nishiyama H, Nonoguchi K, Higashitsuji H, Kishishita M, Fujita J. A novel hsp110-related gene, apg-1, that is abundantly expressed in the testis responds to a low temperature heat shock rather than the traditional elevated temperatures. J Biol Chem. 1997;272:2640–2645.[Abstract/Free Full Text]

161. Kojima R, Randall J, Brenner B, Gullans S. Osmotic stress protein 94 (Osp94): a new member of the Hsp110/SSE gene subfamily. J Biol Chem. 1996;271:12327–12332.[Abstract/Free Full Text]

162. Parsell DA, Kowal AS, Singer MA, Lindquist S. Protein disaggregation mediated by heat-shock protein Hsp104. Nature. 1994;372:475–478.[Medline] [Order article via Infotrieve]

163. Rospert S, Looser R, Dubaquie Y, Matouschek A, Glick BS, Schatz G. Hsp60-independent protein folding in the matrix of yeast mitochondria. EMBO J. 1996;15:764–774.[Medline] [Order article via Infotrieve]

164. Weissman JS, Hohl CM, Kovalenko O, Kashi Y, Chen S, Braig K, Saibil HR, Fenton WA, Horwich AL. Mechanism of GroEL action: productive release of polypeptide from a sequestered position under GroES. Cell. 1995;83:577–587.[Medline] [Order article via Infotrieve]

165. Frydman J, Nimmesgern E, Erdjument-Bromage H, Wall JS, Tempst P, Hartl FU. Function in protein folding of TRiC, a cytosolic ring complex containing TCP-1 and structurally related subunits. EMBO J. 1992;11:4767–4778.[Medline] [Order article via Infotrieve]

166. Hohfeld J, Minami Y, Hartl F. Hip, a novel cochaperone involved in the eukaryotic Hsc70/Hsp40 reaction cycle. Cell. 1995;83:589–598.[Medline] [Order article via Infotrieve]

167. Nishio ML, Ornatsky OI, Craig EE, Hood DA. Mitochondrial biogenesis during pressure overload induced cardiac hypertrophy in adult rats. Can J Physiol Pharmacol. 1995;73:630–637.[Medline] [Order article via Infotrieve]

168. Sohal RS, Ku H-H, Agarwal S, Forster MJ, Lal H. Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse. Mech Ageing Dev. 1994;74:121–133.[Medline] [Order article via Infotrieve]

169. Benjamin IJ, Williams RS. Expression and function of stress proteins in the ischemic heart. In: Morimoto RI, Tissieres A, Georgopoulos S, eds. The Biology of Heat Shock Proteins and Molecular Chaperones. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1994:533–552.

170. Klausner RD, Sitia R. Protein degradation in the endoplasmic reticulum. Cell. 1990;62:611–614.[Medline] [Order article via Infotrieve]

171. Medeiros-Neto G, Kim PS, Yoo SE, Vono J, Targovnik HM, Camargo R, Hossain SA, Arvan P. Congenital hypothyroid goiter with deficient thyroglobulin: identification of an endoplasmic reticulum storage disease with induction of molecular chaperones. J Clin Invest. 1996;98:2838–2844.[Medline] [Order article via Infotrieve]

172. Lin HY, Masso-Welch P, Di YP, Cai JW, Shen JW, Subjeck JR. The 170-kDa glucose-regulated stress protein is an endoplasmic reticulum protein that binds immunoglobulin. Mol Biol Cell. 1993;4:1109–1119.[Abstract]

173. Kilgore JL, Musch TI, Ross CR. Regional distribution of HSP70 proteins after myocardial infraction. Basic Res Cardiol. 1996;91:283–288.[Medline] [Order article via Infotrieve]

174. Nishizawa J, Nakai A, Higashi T, Tanabe M, Nomoto S, Matsuda K, Ban T, Nagata K. Reperfusion causes significant activation of heat shock transcription factor 1 in ischemic rat heart. Circulation. 1996;94:2185–2192.[Abstract/Free Full Text]

175. Nakai A, Satoh M, Hirayoshi K, Nagata K. Involvement of the stress protein HSP47 in procollagen processing in the endoplasmic reticulum. J Cell Biol. 1992;117:903–914.[Abstract/Free Full Text]

176. Satoh M, Hirayoshi K, Yokota S, Hosokawa N, Nagata K. Intracellular interaction of collagen-specific stress protein HSP47 with newly synthesized procollagen. J Cell Biol. 1996;133:469–483.[Abstract/Free Full Text]

177. Nagata K. Hsp47: a collagen-specific molecular chaperone. Trends Biochem Sci. 1996;21:22–26.[Medline] [Order article via Infotrieve]

178. Weber KT, Anversa P, Armstrong PW, Brilla CG, Burnett JC Jr, Cruickshank JM, Devereux RB, Giles TD, Korsgaard N, Leier CV, et al. Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol. 1992;20:3–16.[Abstract]

179. Yoshida T, Maulik N, Engelman RM, Ho YS, Magnenat JL, Rousou JA, Flack JE III, Deaton D, Das DK. Glutathione peroxidase knockout mice are susceptible to myocardial ischemia reperfusion injury. Circulation. 1997;96(suppl II):II-216–II-220.

180. Benjamin IJ, Jalil JE, Tan LB, Cho K, Weber KT, Clark WA. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res. 1989;65:657–670.[Abstract/Free Full Text]

181. Michael LH, Entman ML, Hartley CJ, Youker KA, Zhu J, Hall SR, Hawkins HK, Berens K, Ballantyne CM. Myocardial ischemia and reperfusion: a murine model. Am J Physiol. 1995;269:H2147–H2154.[Abstract/Free Full Text]

182. Sun JZ, Tang XL, Knowlton AA, Park SW, Qiu Y, Bolli R. Late preconditioning against myocardial stunning: an endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs. J Clin Invest. 1995;95:388–403.

183. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124–1136.[Abstract/Free Full Text]

184. Yellon DM, Iliodromitis E, Latchman DS, Van Winkle DM, Downey JM, Williams FM, Williams TJ. Whole body heat stress fails to limit infarct size in the reperfused rabbit heart. Cardiovasc Res. 1992;26:342–346.[Abstract/Free Full Text]

185. Downey JM, Cohen MV, Ytrehus K, Liu Y. Cellular mechanisms in ischemic preconditioning: the role of adenosine and protein kinase C. Ann N Y Acad Sci. 1994;723:82–98.[Medline] [Order article via Infotrieve]

186. Heads RJ, Latchman DS, Yellon DM. Differential stress protein mRNA expression during early ischaemic preconditioning in the rabbit heart and its relationship to adenosine receptor function. J Mol Cell Cardiol. 1995;27:2133–2148.[Medline] [Order article via Infotrieve]

187. Ganote C, Armstrong S. Ischaemia and myocyte cytoskeleton: review and speculation. Cardiovasc Res. 1993;27:1387–1403.[Free Full Text]

188. Liang P, MacRae TH. Molecular chaperones and the cytoskeleton. J Cell Sci. 1997;110:1431–1440.[Abstract]

189. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M, Kamada T, Tada M. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res. 1993;72:1293–1299.[Abstract/Free Full Text]

190. Hoshida S, Kuzuya T, Yamashita N, Oe H, Fuji H, Hori M, Tada M, Kamada T. Brief myocardial ischemia affects free radical generating and scavenging systems in dogs. Heart Vessels. 1993;8:115–120.[Medline] [Order article via Infotrieve]

191. Tang X-L, Qiu Y, Park S-W, Sun J-Z, Kalya A, Bolli R. Time course of late preconditioning against myocardial stunning in conscious pigs. Circ Res. 1996;79:424–434.[Abstract/Free Full Text]

192. Yang XM, Baxter GF, Heads RJ, Yellon DM, Downey JM, Cohen MV. Infarct limitation of the second window of protection in a conscious rabbit model. Cardiovasc Res. 1996;31:777–783.[Medline] [Order article via Infotrieve]

193. Schwarz ER, Whyte WS, Kloner RA. Ischemic preconditioning. Curr Opin Cardiol. 1997;12:475–481.[Medline] [Order article via Infotrieve]

194. Hoag JB, Qian YZ, Nayeem MA, D'Angelo M, Kukreja RC. ATP-sensitive potassium channel mediates delayed ischemic protection by heat stress in rabbit heart. Am J Physiol. 1997;273:H2458–H2464.

195. Brooks G, Hearse DJ. Role of protein kinase C in ischemic preconditioning: player or spectator [editorial]? Circ Res. 1996;79:627–630.

196. DeMeester S, Buchman T, Qiu Y, Jacob A, Dunnigan K, Hotchkiss R, Karl I, Cobb J. Heat shock induces IB- and prevents stress-induced endothelial cell apoptosis. Arch Surg. 1997;132:1283–1287.[Abstract/Free Full Text]

197. Garcia-Bermejo L, Vilaboa N, Perez C, Galan A, De Blas E, Aller P. Modulation of heat-shock protein 70 (HSP70) gene expression by sodium butyrate in U-937 promonocytic cells: relationships with differentiation and apoptosis. Exp Cell Res. 1997;236:268–274.[Medline] [Order article via Infotrieve]

198. Mosser D, Caron A, Bourget L, Denis-Larose C, Massie B. Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol. 1997;17:5317–5327.[Abstract/Free Full Text]

199. Bissonnette RP, Echeverri F, Mahboubi A, Green DR. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature. 1992;359:552–554.[Medline] [Order article via Infotrieve]

200. Li WX, Chen CH, Ling CC, Li GC. Apoptosis in heat-induced cell killing: the protective role of hsp-70 and the sensitization effect of the c-myc gene. Radiat Res. 1996;145:324–330.[Medline] [Order article via Infotrieve]

201. Strasser A, Anderson RL. Bcl-2 and thermotolerance cooperate in cell survival. Cell Growth Differ. 1995;6:799–805.[Abstract]

202. Dix DJ, Allen JW, Collins BW, Mori C, Nakamura N, Poorman-Allen P, Goulding EH, Reddy EM. Targeted gene disruption of Hsp70–2 results in failed meiosis, germ cell apoptosis, and male fertility. Proc Natl Acad Sci U S A.. 1996;93:3264–3268.[Abstract/Free Full Text]

203. Gabai V, Meriin A, Mosser D, Caron A, Rits S, Shifrin V, Sherman M. Hsp70 prevents activation of stress kinases. J Biol Chem. 1997;272:18033–18037.[Abstract/Free Full Text]

204. Polla BS, Kantengwa S, Francois D, Salvioli S, Franceschi C, Marsac C, Cossarizza A, Jacquier-Sarlin MR, Polla BS. Mitochondria are selective targets for the protective effects of heat shock against oxidative injury: dual regulation of heat-shock transcription factor (HSF) activation and DNA-binding activity by H2O2: role of thioredoxin. Proc Natl Acad Sci U S A.. 1996;93:6458–6463.[Abstract/Free Full Text]

205. Kohno T, Yamada Y, Hata T, Mori H, Yamamura M, Tomonaga M, Urata Y, Goto S, Kondo T. Relation of oxidative stress and glutathione synthesis to CD95(Fas/APO-1)-mediated apoptosis of adult T cell leukemia cells. J Immunol. 1996;156:4722–4728.[Abstract]

206. Mehlen P, Schulze-Osthoff K, Arrigo AP. Small stress proteins as novel regulators of apoptosis: heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death. J Biol Chem. 1996;271:16510–16514.[Abstract/Free Full Text]

207. Kohane DS, Sarzani R, Schwartz JH, Chobanian AV, Brecher P. Stress-induced proteins in aortic smooth muscle cells and aorta of hypertensive rats. Am J Physiol. 1990;258:H1699–H1705.[Abstract/Free Full Text]

208. Xu Q, Li DG, Holbrook NJ, Udelsman R. Acute hypertension induces heat-shock protein 70 gene expression in rat aorta. Circulation. 1995;92:1223–1229.[Abstract/Free Full Text]

209. Patton WF, Erdjument-Bromage H, Marks AR, Tempst P, Taubman MB. Components of the protein synthesis and folding machinery are induced in vascular smooth muscle cells by hypertrophic and hyperplastic agents: identification by comparative protein phenotyping and microsequencing. J Biol Chem. 1995;270:21404–21410.[Abstract/Free Full Text]

210. Locke M, Tanguay RM. Diminished heat shock response in the aged myocardium. Cell Stress Chaperones. 1996;1:251–260.[Medline] [Order article via Infotrieve]

211. Sohal RS. Role of mitochondria and oxidative stress in the aging process. In: Beal MF, Howell N, Bodis-Wollner I, eds. Mitochondria and Free Radicals in Neurogenerative Diseases. New York, NY: Wiley-Liss Inc; 1997.

212. Robbins J. -Tropomyosin knockouts: a blow against transcriptional chauvinism. Circ Res. 1998;82:134–136.[Free Full Text]

213. Geisterfer-Lowrance AA, Christe M, Conner DA, Ingwall JS, Schoen FJ, Seidman CE, Seidman JG. A mouse model of familial hypertrophic cardiomyopathy. Science. 1996;272:731–734.[Abstract]

214. Sullivan TR Jr, Karas RH, Aronovitz M, Faller GT, Ziar JP, Smith JJ, O'Donnell TF Jr, Mendelsohn ME. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest. 1995;96:2482–2488.

215. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR Jr, Lubahn DB, O'Donnell TF Jr, Korach KS, Mendelsohn ME. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat Med. 1997;3:545–548.[Medline] [Order article via Infotrieve]

216. Lobo RA, Speroff L. International consensus conference on postmenopausal hormone therapy and the cardiovascular system [editorial]. Fertil Steril. 1994;61:592–595.[Medline] [Order article via Infotrieve]

217. Marchant DJ. Supplemental estrogen replacement. Cancer. 1994;74:512–517.[Medline] [Order article via Infotrieve]

218. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med. 1976;85:447–452.

219. Castelli WP. Epidemiology of coronary heart disease: the Framingham study. Am J Med. 1984;76:4–12.[Medline] [Order article via Infotrieve]

220. Kannel WB, Wilson PW. Risk factors that attenuate the female coronary disease advantage. Arch Intern Med. 1995;155:57–61.[Abstract/Free Full Text]

221. Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen. FASEB J. 1996;10:615–624.[Abstract]

222. Xu Q, Wick G. The role of heat shock proteins in protection and pathophysiology of the arterial wall. Mol Med Today. 1996;2:372–379.[Medline] [Order article via Infotrieve]

223. Kleindienst R, Schett G, Amberger A, Seitz CS, Michaelis D, Metzler B, Dietrich H, Xu Q, Wick G. Atherosclerosis as an autoimmune condition. Isr J Med Sci. 1995;31:596–599.[Medline] [Order article via Infotrieve]

224. Schett G, Xu Q, Amberger A, Van der Zee R, Recheis H, Willeit J, Wick G. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest. 1995;96:2569–2577.

224A. Krautz GM, Peterson JD, Godsel LM, Krettli AU, Engman DM. Human antibody responses to Trypanosoma cruzi 70-kD heat-shock proteins. Am J Trop Med Hyg. 1998;58:137–143.[Abstract]

225. Bush KT, Goldberg AL, Nigam SK. Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance. J Biol Chem. 1997;272:9086–9092.[Abstract/Free Full Text]

226. Gottesfeld JM, Neely L, Trauger JW, Baird EE, Dervan PB. Regulation of gene expression by small molecules. Nature. 1997;387:202–205.[Medline] [Order article via Infotrieve]

226A. Vigh L, Literati PN, Horvath I, Torok Z, Balogh G, Glatz A, Kovacs E, Boros I, Ferdinandy P, Farkas B, Jaszlits L, Jednakovits A, Koranyi L, Maresca B. Bimoclomol: a nontoxic, hydroxylamine derivative with stress-protein activity and cytoprotective effects. Nat Med. 1997;3:1150–1154.[Medline] [Order article via Infotrieve]

227. Black SC, Lucchesi BR. Heat shock proteins and the ischemic heart: an endogenous protective mechanism [editorial comment]. Circulation. 1993;87:1048–1051.[Free Full Text]

228. Shen AC, Jennings RB. Myocardial calcium and magnesium in acute ischemic injury. Am J Pathol. 1972;67:417–440.[Medline] [Order article via Infotrieve]

229. Jennings RB, Shen AC. Calcium in experimental myocardial ischemia. Recent Adv Stud Cardiac Struct Metab. 1972;1:639–655.[Medline] [Order article via Infotrieve]

230. Dayton WR, Goll DE, Zeece MG, Robson RM, Reville WJ. A Ca²⁺-activated protease possibly involved in myofibrillar protein turnover: purification from porcine muscle. Biochemistry. 1976;15:2150–2158.[Medline] [Order article via Infotrieve]

231. Dayton WR, Schollmeyer JV. Isolation from porcine cardiac muscle of a Ca²⁺-activated protease that partially degrades myofibrils. J Mol Cell Cardiol. 1980;12:533–551.[Medline] [Order article via Infotrieve]

232. Ganote CE, Nayler WG. Contracture and the calcium paradox. J Mol Cell Cardiol. 1985;17:733–745.[Medline] [Order article via Infotrieve]

233. Kilgore KS, Lucchesi BR. Reperfusion injury after myocardial infarction: the role of free radicals and the inflammatory response. Clin Biochem. 1993;26:359–370.[Medline] [Order article via Infotrieve]

234. Barraclough R, Ellis RJ. Protein synthesis in chloroplasts, IX: assembly of newly-synthesized large subunits into ribulose bisphosphate carboxylase in isolated intact pea chloroplasts. Biochim Biophys Acta. 1980;608:19–31.[Medline] [Order article via Infotrieve]

235. Ellis RJ. The general concept of molecular chaperones. Philos Trans R Soc Lond B Biol Sci. 1993;339:257–261.

236. Polla BS, Jacquier-Sarlin MR, Kantengwa S, Mariethoz E, Hennet T, Russo-Marie F, Cossarizza A. TNF alpha alters mitochondrial membrane potential in L929 but not in TNF alpha-resistant L929.12 cells: relationship with the expression of stress proteins, annexin 1 and superoxide dismutase activity. Free Radic Res. 1996;25:125–131.[Medline] [Order article via Infotrieve]

237. Jennings RB, Murry CE, Steenbergen C Jr, Reimer KA. Development of cell injury in sustained acute ischemia. Circulation. 1990;82(suppl II):II-2–II-12.

238. Medina R, Wing SS, Goldberg AL. Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Biochem J. 1995;307:631–637.

239. Sherman MY, Goldberg AL. Involvement of molecular chaperones in intracellular protein breakdown. EXS. 1996;77:57–78.[Medline] [Order article via Infotrieve]

240. Cahill CM, Waterman WR, Xie Y, Auron PE, Calderwood SK. Transcriptional repression of the prointerleukin 1beta gene by heat shock factor 1. J Biol Chem. 1996;271:24874–24879.[Free Full Text]

241. Jacquier-Sarlin MR, Fuller K, Dinh-Xuan AT, Richard MJ, Polla BS. Protective effects of hsp70 in inflammation. Experientia. 1994;50:1031–1038.[Medline] [Order article via Infotrieve]

242. Malyshev I, Manukhina EB, Mikoyan VD, Kubrina LN, Vanin AF. Nitric oxide is involved in heat-induced HSP70 accumulation. FEBS Lett. 1995;370:159–162.[Medline] [Order article via Infotrieve]

243. Malyshev I, Malugin AV, Golubeva L, Zenina TA, Manukhina EB, Mikoyan VD, Vanin AF. Nitric oxide donor induces HSP70 accumulation in the heart and in cultured cells. FEBS Lett. 1996;391:21–23.[Medline] [Order article via Infotrieve]

244. Chi SH, Mestril R. Stable expression of a human HSP70 gene in a rat myogenic cell line confers protection against endotoxin. Am J Physiol. 1996;270:C1017–C1021.[Abstract/Free Full Text]

245. Wang D, McMillin JB, Bick R, Buja LM. Response of the neonatal rat cardiomyocyte in culture to energy depletion: effects of cytokines, nitric oxide, and heat shock proteins. Lab Invest. 1996;75:809–818.[Medline] [Order article via Infotrieve]

246. Malyshev I, Malugin AV, Manukhina EB, Larionov NP, Malenyuk EB, Malysheva EV, Mikoyan VD, Vanin AF. Is HSP70 involved in nitric oxide-induced protection of the heart? Physiol Res. 1996;45:267–272.[Medline] [Order article via Infotrieve]

247. Prapapanich V, Chen S, Nair S, Rimerman R, Smith D. Molecular cloning of human p48, a transient component of progesterone receptor complexes and an Hsp70-binding protein. Mol Endocrinol. 1996;10:420–431.[Abstract/Free Full Text]

248. Chen S, Prapapanich V, Rimerman RA, Honoré B, DF Smith. Interactions of p60, a mediator of progesterone receptor assembly, with heat shock proteins hsp90 and hsp70. Mol Endocrinol. 1996;10:682–693.[Abstract/Free Full Text]

249. Gross M, Hessefort S. Purification and characterization of a 66-kDa protein from rabbit reticulocyte lysate which promotes the recycling of hsp 70. J Biol Chem. 1996;271:16833–16841.[Abstract/Free Full Text]

250. Takayama S, Bimston DN, Matsuzawa S, Freeman BC, Aime-Sempe C, Xie Z, Morimoto RI, Reed JC. BAG-1 modulates the chaperone activity of Hsp70/Hsc70. EMBO J. 1997;16:4887–4896.[Medline] [Order article via Infotrieve]

This article has been cited by other articles:

				J. Qian, X. Ren, X. Wang, P. Zhang, W. K. Jones, J. D. Molkentin, G.-C. Fan, and E. G. Kranias Blockade of Hsp20 Phosphorylation Exacerbates Cardiac Ischemia/Reperfusion Injury by Suppressed Autophagy and Increased Cell Death Circ. Res., December 4, 2009; 105(12): 1223 - 1231. [Abstract] [Full Text] [PDF]

				V Dudeja, S M Vickers, and A K Saluja The role of heat shock proteins in gastrointestinal diseases Gut, July 1, 2009; 58(7): 1000 - 1009. [Abstract] [Full Text] [PDF]

				Y. Murozono, N. Takahashi, T. Shinohara, T. Ooie, Y. Teshima, M. Hara, T. Saikawa, and H. Yoshimatsu Hyperthermia-Induced Cardioprotection Is Potentiated by Ischemic Postconditioning in Rats Exp Biol Med, May 1, 2009; 234(5): 573 - 581. [Abstract] [Full Text] [PDF]

				Y. Torigoe, N. Takahashi, M. Hara, H. Yoshimatsu, and T. Saikawa Adrenomedullin Improves Cardiac Expression of Heat-Shock Protein 72 and Tolerance against Ischemia/Reperfusion Injury in Insulin-Resistant Rats Endocrinology, March 1, 2009; 150(3): 1450 - 1455. [Abstract] [Full Text] [PDF]

				G.-C. Fan, X. Zhou, X. Wang, G. Song, J. Qian, P. Nicolaou, G. Chen, X. Ren, and E. G. Kranias Heat Shock Protein 20 Interacting With Phosphorylated Akt Reduces Doxorubicin-Triggered Oxidative Stress and Cardiotoxicity Circ. Res., November 21, 2008; 103(11): 1270 - 1279. [Abstract] [Full Text] [PDF]

				M. Matsumoto, P. C. Dimayuga, C. Wang, J. Kirzner, M. Cercek, J. Yano, K.-Y. Chyu, P. K. Shah, and B. Cercek Exogenous heat shock protein-70 inhibits cigarette smoke-induced intimal thickening Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2008; 295(4): R1320 - R1327. [Abstract] [Full Text] [PDF]

				P. S. Pagel Induction of Heat Shock Protein 70 and Preconditioning by Sevoflurane: A Potent Protective Interaction Against Myocardial Ischemia-Reperfusion Injury Anesth. Analg., September 1, 2008; 107(3): 742 - 745. [Full Text] [PDF]

				H. Kitahata, J. Nozaki, S. Kawahito, T. Tomino, and S. Oshita Low-Dose Sevoflurane Inhalation Enhances Late Cardioprotection from the Anti-Ulcer Drug Geranylgeranylacetone Anesth. Analg., September 1, 2008; 107(3): 755 - 761. [Abstract] [Full Text] [PDF]

				R. Matsushima-Nishiwaki, S. Takai, S. Adachi, C. Minamitani, E. Yasuda, T. Noda, K. Kato, H. Toyoda, Y. Kaneoka, A. Yamaguchi, et al. Phosphorylated Heat Shock Protein 27 Represses Growth of Hepatocellular Carcinoma via Inhibition of Extracellular Signal-regulated Kinase J. Biol. Chem., July 4, 2008; 283(27): 18852 - 18860. [Abstract] [Full Text] [PDF]

				J. McGuinness, J. Byrne, C. Condron, J. McCarthy, D. Bouchier-Hayes, and J. M. Redmond Pretreatment with {omega}-3 fatty acid infusion to prevent leukocyte-endothelial injury responses seen in cardiac surgery J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 135 - 141. [Abstract] [Full Text] [PDF]

				J.-K. Park, N. Ronkina, A. Hoft, C. Prohl, J. Menne, M. Gaestel, H. Haller, and M. Meier Deletion of MK2 signalling in vivo inhibits small Hsp phosphorylation but not diabetic nephropathy Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1844 - 1853. [Abstract] [Full Text] [PDF]

				B. J.J.M. Brundel, L. Ke, A.-J. Dijkhuis, X. Qi, A. Shiroshita-Takeshita, S. Nattel, R. H. Henning, and H. H. Kampinga Heat shock proteins as molecular targets for intervention in atrial fibrillation Cardiovasc Res, June 1, 2008; 78(3): 422 - 428. [Abstract] [Full Text] [PDF]

				M. Sakabe, A. Shiroshita-Takeshita, A. Maguy, B. J.J.M. Brundel, A. Fujiki, H. Inoue, and S. Nattel Effects of a heat shock protein inducer on the atrial fibrillation substrate caused by acute atrial ischaemia Cardiovasc Res, April 1, 2008; 78(1): 63 - 70. [Abstract] [Full Text] [PDF]

				S. I. Rattan Principles and practice of hormetic treatment of aging and age-related diseases Human and Experimental Toxicology, February 1, 2008; 27(2): 151 - 154. [Abstract] [PDF]

				C. Brasselet, E. Durand, F. Addad, F. Vitry, G. Chatellier, C. Demerens, M. Lemitre, R. Garnotel, D. Urbain, P. Bruneval, et al. Effect of local heating on restenosis and in-stent neointimal hyperplasia in the atherosclerotic rabbit model: a dose-ranging study Eur. Heart J., February 1, 2008; 29(3): 402 - 412. [Abstract] [Full Text] [PDF]

				G. Bolotin, J. Raman, U. Williams, E. Bacha, M. Kocherginsky, and V. Jeevanandam Glutamine Improves Myocardial Function Following Ischemia-Reperfusion Injury Asian Cardiovasc Thorac Ann, December 1, 2007; 15(6): 463 - 467. [Abstract] [Full Text] [PDF]

				G.H.M. van Puijvelde, T. van Es, E.J.A. van Wanrooij, K.L.L. Habets, P. de Vos, R. van der Zee, W. van Eden, Th. J.C. van Berkel, and J. Kuiper Induction of Oral Tolerance to HSP60 or an HSP60-Peptide Activates T Cell Regulation and Reduces Atherosclerosis Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2677 - 2683. [Abstract] [Full Text] [PDF]

				C. W. J. Melling, D. B. Thorp, K. J. Milne, M. P. Krause, and E. G. Noble Exercise-mediated regulation of Hsp70 expression following aerobic exercise training Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3692 - H3698. [Abstract] [Full Text] [PDF]

				I. J. Benjamin, Y. Guo, S. Srinivasan, S. Boudina, R. P. Taylor, N. S. Rajasekaran, R. Gottlieb, E. F. Wawrousek, E. D. Abel, and R. Bolli CRYAB and HSPB2 deficiency alters cardiac metabolism and paradoxically confers protection against myocardial ischemia in aging mice Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3201 - H3209. [Abstract] [Full Text] [PDF]

				W. Huang, J. B. Fileta, T. Filippopoulos, A. Ray, A. Dobberfuhl, and C. L. Grosskreutz Hsp27 Phosphorylation in Experimental Glaucoma Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4129 - 4135. [Abstract] [Full Text] [PDF]

				T. Shinohara, N. Takahashi, H. Kohno, K. Yamanaka, T. Ooie, O. Wakisaka, Y. Murozono, Y. Taniguchi, Y. Torigoe, M. Hara, et al. Mitochondria are targets for geranylgeranylacetone-induced cardioprotection against ischemia-reperfusion in the rat heart Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1892 - H1899. [Abstract] [Full Text] [PDF]

				L. Liu, X. Zhang, B. Qian, X. Min, X. Gao, C. Li, Y. Cheng, and J. Huang Over-expression of heat shock protein 27 attenuates doxorubicin-induced cardiac dysfunction in mice Eur J Heart Fail, August 1, 2007; 9(8): 762 - 769. [Abstract] [Full Text] [PDF]

				H. Kohno, N. Takahashi, T. Shinohara, T. Ooie, K. Yufu, M. Nakagawa, H. Yonemochi, M. Hara, T. Saikawa, and H. Yoshimatsu Receptor-Mediated Suppression of Cardiac Heat-Shock Protein 72 Expression by Testosterone in Male Rat Heart Endocrinology, July 1, 2007; 148(7): 3148 - 3155. [Abstract] [Full Text] [PDF]

				C. HEALY, K. J. MULHALL, D. F. PATRICK, E. W. KAY, and D. BOUCHIER-HAYES THE EFFECT OF THERMAL PRECONDITIONING OF THE LIMB ON FLEXOR TENDON HEALING J Hand Surg Eur Vol., June 1, 2007; 32(3): 289 - 295. [Abstract] [Full Text] [PDF]

				S. D. Coaxum, T. M. Griffin, J. L. Martin, and R. Mestril Influence of PKC-{alpha} overexpression on HSP70 and cardioprotection Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2220 - H2226. [Abstract] [Full Text] [PDF]

				A. Thawornkaiwong, J. Pantharanontaga, and J. Wattanapermpool Hypersensitivity of myofilament response to Ca2+ in association with maladaptation of estrogen-deficient heart under diabetes complication Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R844 - R851. [Abstract] [Full Text] [PDF]

				M. Sakamoto, T. Minamino, H. Toko, Y. Kayama, Y. Zou, M. Sano, E. Takaki, T. Aoyagi, K. Tojo, N. Tajima, et al. Upregulation of Heat Shock Transcription Factor 1 Plays a Critical Role in Adaptive Cardiac Hypertrophy Circ. Res., December 8, 2006; 99(12): 1411 - 1418. [Abstract] [Full Text] [PDF]

				B. J. J. M. Brundel, A. Shiroshita-Takeshita, X. Qi, Y.-H. Yeh, D. Chartier, I. C. van Gelder, R. H. Henning, H. H. Kampinga, and S. Nattel Induction of Heat Shock Response Protects the Heart Against Atrial Fibrillation Circ. Res., December 8, 2006; 99(12): 1394 - 1402. [Abstract] [Full Text] [PDF]

				S. C. Jeyaraj, D. Dakhlallah, S. R. Hill, and B. S. Lee Expression and distribution of HuR during ATP depletion and recovery in proximal tubule cells Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1255 - F1263. [Abstract] [Full Text] [PDF]

				G.-C. Fan, Q. Yuan, G. Song, Y. Wang, G. Chen, J. Qian, X. Zhou, Y. J. Lee, M. Ashraf, and E. G. Kranias Small Heat-Shock Protein Hsp20 Attenuates {beta}-Agonist-Mediated Cardiac Remodeling Through Apoptosis Signal-Regulating Kinase 1 Circ. Res., November 24, 2006; 99(11): 1233 - 1242. [Abstract] [Full Text] [PDF]

				H.-J. Lee, Y.-J. Lee, H.-C. Kwon, S. Bae, S.-H. Kim, J.-J. Min, C.-K. Cho, and Y.-S. Lee Radioprotective Effect of Heat Shock Protein 25 on Submandibular Glands of Rats Am. J. Pathol., November 1, 2006; 169(5): 1601 - 1611. [Abstract] [Full Text] [PDF]

				P. Rafiee, M. E. Theriot, V. M. Nelson, J. Heidemann, Y. Kanaa, S. A. Horowitz, A. Rogaczewski, C. P. Johnson, I. Ali, R. Shaker, et al. Human esophageal microvascular endothelial cells respond to acidic pH stress by PI3K/AKT and p38 MAPK-regulated induction of Hsp70 and Hsp27 Am J Physiol Cell Physiol, November 1, 2006; 291(5): C931 - C945. [Abstract] [Full Text] [PDF]

				J. D. Joo, M. Kim, V. D. D'Agati, and H. T. Lee Ischemic Preconditioning Provides Both Acute and Delayed Protection against Renal Ischemia and Reperfusion Injury in Mice J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3115 - 3123. [Abstract] [Full Text] [PDF]

				Y. Taniguchi, T. Ooie, N. Takahashi, T. Shinohara, M. Nakagawa, H. Yonemochi, M. Hara, H. Yoshimatsu, and T. Saikawa Pioglitazone but not glibenclamide improves cardiac expression of heat shock protein 72 and tolerance against ischemia/reperfusion injury in the heredity insulin-resistant rat. Diabetes, August 1, 2006; 55(8): 2371 - 2378. [Abstract] [Full Text] [PDF]

				J. L. C. Bilszta, G. J. Dusting, and F. Jiang Arsenite Increases Vasoconstrictor Reactivity in Rat Blood Vessels: Role of Endothelial Nitric Oxide Function International Journal of Toxicology, July 1, 2006; 25(4): 303 - 310. [Abstract] [Full Text] [PDF]

				I. J. Benjamin Viewing a Stressful Episode of ER: Is ATF6 the Triage Nurse? Circ. Res., May 12, 2006; 98(9): 1120 - 1122. [Full Text] [PDF]

				T. Shinohara, N. Takahashi, T. Ooie, M. Hara, S. Shigematsu, M. Nakagawa, H. Yonemochi, T. Saikawa, and H. Yoshimatsu Phosphatidylinositol 3-kinase-dependent activation of akt, an essential signal for hyperthermia-induced heat-shock protein 72, is attenuated in streptozotocin-induced diabetic heart. Diabetes, May 1, 2006; 55(5): 1307 - 1315. [Abstract] [Full Text] [PDF]

				E. H. Miyabara, J. L. Martin, T. M. Griffin, A. S. Moriscot, and R. Mestril Overexpression of inducible 70-kDa heat shock protein in mouse attenuates skeletal muscle damage induced by cryolesioning Am J Physiol Cell Physiol, April 1, 2006; 290(4): C1128 - C1138. [Abstract] [Full Text] [PDF]

				Q. Xiao, K. Mandal, G. Schett, M. Mayr, G. Wick, F. Oberhollenzer, J. Willeit, S. Kiechl, and Q. Xu Association of Serum-Soluble Heat Shock Protein 60 With Carotid Atherosclerosis: Clinical Significance Determined in a Follow-Up Study Stroke, December 1, 2005; 36(12): 2571 - 2576. [Abstract] [Full Text] [PDF]

				K Mandal, G Foteinos, M Jahangiri, and Q Xu Role of antiheat shock protein 60 autoantibodies in atherosclerosis Lupus, September 1, 2005; 14(9): 742 - 746. [Abstract] [PDF]

				M. A. Laflamme, J. Gold, C. Xu, M. Hassanipour, E. Rosler, S. Police, V. Muskheli, and C. E. Murry Formation of Human Myocardium in the Rat Heart from Human Embryonic Stem Cells Am. J. Pathol., September 1, 2005; 167(3): 663 - 671. [Abstract] [Full Text] [PDF]

				W. M. Armstead and J. G. Hecker Heat shock protein modulation of KATP and KCa channel cerebrovasodilation after brain injury Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1184 - H1190. [Abstract] [Full Text] [PDF]

				M.-N. Giraud, M. Fluck, C. Zuppinger, and T. M. Suter Expressional reprogramming of survival pathways in rat cardiocytes by neuregulin-1{beta} J Appl Physiol, July 1, 2005; 99(1): 313 - 322. [Abstract] [Full Text] [PDF]

				A. V. Cybulsky, T. Takano, J. Papillon, and K. Bijian Role of the Endoplasmic Reticulum Unfolded Protein Response in Glomerular Epithelial Cell Injury J. Biol. Chem., July 1, 2005; 280(26): 24396 - 24403. [Abstract] [Full Text] [PDF]

				W. Wang, L. Jia, T. Wang, W. Sun, S. Wu, and X. Wang Endogenous Calcitonin Gene-related Peptide Protects Human Alveolar Epithelial Cells through Protein Kinase C{epsilon} and Heat Shock Protein J. Biol. Chem., May 27, 2005; 280(21): 20325 - 20330. [Abstract] [Full Text] [PDF]

				G.-C. Fan, X. Ren, J. Qian, Q. Yuan, P. Nicolaou, Y. Wang, W. K. Jones, G. Chu, and E. G. Kranias Novel Cardioprotective Role of a Small Heat-Shock Protein, Hsp20, Against Ischemia/Reperfusion Injury Circulation, April 12, 2005; 111(14): 1792 - 1799. [Abstract] [Full Text] [PDF]

				K. Mandal, E. Torsney, J. Poloniecki, A. J. Camm, Q. Xu, and M. Jahangiri Association of High Intracellular, But Not Serum, Heat Shock Protein 70 With Postoperative Atrial Fibrillation Ann. Thorac. Surg., March 1, 2005; 79(3): 865 - 871. [Abstract] [Full Text] [PDF]

				H. Miller, S. Poon, B. Hibbert, K. Rayner, Y.-X. Chen, and E. R. O'Brien Modulation of Estrogen Signaling by the Novel Interaction of Heat Shock Protein 27, a Biomarker for Atherosclerosis, and Estrogen Receptor {beta}: Mechanistic Insight Into the Vascular Effects of Estrogens Arterioscler Thromb Vasc Biol, March 1, 2005; 25(3): e10 - e14. [Abstract] [Full Text] [PDF]

				B. C. Blunt, Y. Chen, J. D. Potter, and P. A. Hofmann Modest actomyosin energy conservation increases myocardial postischemic function Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1088 - H1096. [Abstract] [Full Text] [PDF]

				M. Wellner, R. Dechend, J.-K. Park, E. Shagdarsuren, N. Al-Saadi, T. Kirsch, P. Gratze, W. Schneider, S. Meiners, A. Fiebeler, et al. Cardiac gene expression profile in rats with terminal heart failure and cachexia Physiol Genomics, February 10, 2005; 20(3): 256 - 267. [Abstract] [Full Text] [PDF]

				S. P. Anderson, P. Howroyd, J. Liu, X. Qian, R. Bahnemann, C. Swanson, M.-K. Kwak, T. W. Kensler, and J. C. Corton The Transcriptional Response to a Peroxisome Proliferator-activated Receptor {alpha} Agonist Includes Increased Expression of Proteome Maintenance Genes J. Biol. Chem., December 10, 2004; 279(50): 52390 - 52398. [Abstract] [Full Text] [PDF]

				C.-L. Su, C.-P. Wu, S.-Y. Chen, B.-H. Kang, K.-L. Huang, and Y.-C. Lin Acclimatization to neurological decompression sickness in rabbits Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1214 - R1218. [Abstract] [Full Text] [PDF]

				K. Mandal, M. Jahangiri, M. Mukhin, J. Poloniecki, A. J. Camm, and Q. Xu Association of Anti-Heat Shock Protein 65 Antibodies With Development of Postoperative Atrial Fibrillation Circulation, October 26, 2004; 110(17): 2588 - 2590. [Abstract] [Full Text] [PDF]

				H. Hamada, M. Suzuki, S. Yuasa, N. Mimura, N. Shinozuka, Y. Takada, M. Suzuki, T. Nishino, H. Nakaya, H. Koseki, et al. Dilated Cardiomyopathy Caused by Aberrant Endoplasmic Reticulum Quality Control in Mutant KDEL Receptor Transgenic Mice Mol. Cell. Biol., September 15, 2004; 24(18): 8007 - 8017. [Abstract] [Full Text] [PDF]

				S. Vogt, I. Portig, B. Kusch, S. Pankuweit, A. S. Sirat, D. Troitzsch, B. Maisch, and R. Moosdorf Detection of anti-hsp70 immunoglobulin G antibodies indicates better outcome in coronary artery bypass grafting patients suffering from severe preoperative angina Ann. Thorac. Surg., September 1, 2004; 78(3): 883 - 889. [Abstract] [Full Text] [PDF]

				T. M. Griffin, T. V. Valdez, and R. Mestril Radicicol activates heat shock protein expression and cardioprotection in neonatal rat cardiomyocytes Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1081 - H1088. [Abstract] [Full Text] [PDF]

				M. Atalay, N. K. J. Oksala, D. E. Laaksonen, S. Khanna, C. Nakao, J. Lappalainen, S. Roy, O. Hanninen, and C. K. Sen Exercise training modulates heat shock protein response in diabetic rats J Appl Physiol, August 1, 2004; 97(2): 605 - 611. [Abstract] [Full Text] [PDF]

				T. Shinka, Y. Sato, G. Chen, T. Naroda, K. Kinoshita, Y. Unemi, K. Tsuji, K. Toida, T. Iwamoto, and Y. Nakahori Molecular Characterization of Heat Shock-Like Factor Encoded on the Human Y Chromosome, and Implications for Male Infertility Biol Reprod, July 1, 2004; 71(1): 297 - 306. [Abstract] [Full Text] [PDF]

				J. Wiese, S. McPherson, M. C. Odden, and M. G. Shlipak Effect of Opuntia ficus indica on Symptoms of the Alcohol Hangover Arch Intern Med, June 28, 2004; 164(12): 1334 - 1340. [Abstract] [Full Text] [PDF]

				G.-C. Fan, G. Chu, B. Mitton, Q. Song, Q. Yuan, and E. G. Kranias Small Heat-Shock Protein Hsp20 Phosphorylation Inhibits {beta}-Agonist-Induced Cardiac Apoptosis Circ. Res., June 11, 2004; 94(11): 1474 - 1482. [Abstract] [Full Text] [PDF]

				M. Okada, N. Hasebe, Y. Aizawa, K. Izawa, J.-i. Kawabe, and K. Kikuchi Thermal Treatment Attenuates Neointimal Thickening With Enhanced Expression of Heat-Shock Protein 72 and Suppression of Oxidative Stress Circulation, April 13, 2004; 109(14): 1763 - 1768. [Abstract] [Full Text] [PDF]

				N. C Chi and J. S Karliner Molecular determinants of responses to myocardial ischemia/reperfusion injury: focus on hypoxia-inducible and heat shock factors Cardiovasc Res, February 15, 2004; 61(3): 437 - 447. [Abstract] [Full Text] [PDF]

				Y. Zou, W. Zhu, M. Sakamoto, Y. Qin, H. Akazawa, H. Toko, M. Mizukami, N. Takeda, T. Minamino, H. Takano, et al. Heat Shock Transcription Factor 1 Protects Cardiomyocytes From Ischemia/Reperfusion Injury Circulation, December 16, 2003; 108(24): 3024 - 3030. [Abstract] [Full Text] [PDF]

				P. Rafiee, Y. Shi, K. A. Pritchard Jr., H. Ogawa, A. L. W. Eis, R. A. Komorowski, C. M. Fitzpatrick, J. S. Tweddell, S. B. Litwin, K. Mussatto, et al. Cellular Redistribution of Inducible Hsp70 Protein in the Human and Rabbit Heart in Response to the Stress of Chronic Hypoxia: ROLE OF PROTEIN KINASES J. Biol. Chem., October 31, 2003; 278(44): 43636 - 43644. [Abstract] [Full Text] [PDF]

				C.-C. Hung, T. Ichimura, J. L. Stevens, and J. V. Bonventre Protection of Renal Epithelial Cells against Oxidative Injury by Endoplasmic Reticulum Stress Preconditioning Is Mediated by ERK1/2 Activation J. Biol. Chem., August 1, 2003; 278(31): 29317 - 29326. [Abstract] [Full Text] [PDF]

				C. R. Hampton, A. Shimamoto, C. L. Rothnie, J. Griscavage-Ennis, A. Chong, D. J. Dix, E. D. Verrier, and T. H. Pohlman HSP70.1 and -70.3 are required for late-phase protection induced by ischemic preconditioning of mouse hearts Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H866 - H874. [Abstract] [Full Text] [PDF]

				B. Bartling, I. Friedrich, R.-E. Silber, and A. Simm Ischemic preconditioning is not cardioprotective in senescent human myocardium Ann. Thorac. Surg., July 1, 2003; 76(1): 105 - 111. [Abstract] [Full Text] [PDF]

				A.K. Ghosh and K. Ghosh Increase of heat shock protein with exercise QJM, July 1, 2003; 96(7): 543 - 543. [Full Text] [PDF]

				T. P. Cappola, L. Cope, A. Cernetich, L. A. Barouch, K. Minhas, R. A. Irizarry, G. Parmigiani, S. Durrani, T. Lavoie, E. P. Hoffman, et al. Deficiency of different nitric oxide synthase isoforms activates divergent transcriptional programs in cardiac hypertrophy Physiol Genomics, June 24, 2003; 14(1): 25 - 34. [Abstract] [Full Text] [PDF]

				M. B. Harris, M. A. Blackstone, H. Ju, V. J. Venema, and R. C. Venema Heat-induced increases in endothelial NO synthase expression and activity and endothelial NO release Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H333 - H340. [Abstract] [Full Text] [PDF]

				M. T. Akbar, A. M. C. Lundberg, K. Liu, S. Vidyadaran, K. E. Wells, H. Dolatshad, S. Wynn, D. J. Wells, D. S. Latchman, and J. de Belleroche The Neuroprotective Effects of Heat Shock Protein 27 Overexpression in Transgenic Animals against Kainate-induced Seizures and Hippocampal Cell Death J. Biol. Chem., May 23, 2003; 278(22): 19956 - 19965. [Abstract] [Full Text] [PDF]

				K.-L. Huang, C.-P. Wu, Y.-L. Chen, B.-H. Kang, and Y.-C. Lin Heat stress attenuates air bubble-induced acute lung injury: a novel mechanism of diving acclimatization J Appl Physiol, April 1, 2003; 94(4): 1485 - 1490. [Abstract] [Full Text] [PDF]

				C. Depre, L. Wang, J. E. Tomlinson, V. Gaussin, M. Abdellatif, J. N. Topper, and S. F. Vatner Characterization of pDJA1, a cardiac-specific chaperone found by genomic profiling of the post-ischemic swine heart Cardiovasc Res, April 1, 2003; 58(1): 126 - 135. [Abstract] [Full Text] [PDF]

				P. L. Hooper Diabetes, Nitric Oxide, and Heat Shock Proteins Diabetes Care, March 1, 2003; 26(3): 951 - 952. [Full Text] [PDF]

				M. de Perrot, M. Liu, T. K. Waddell, and S. Keshavjee Ischemia-Reperfusion-induced Lung Injury Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 490 - 511. [Abstract] [Full Text] [PDF]

				C. Depre, M. Hase, V. Gaussin, A. Zajac, L. Wang, L. Hittinger, B. Ghaleh, X. Yu, R. K. Kudej, T. Wagner, et al. H11 Kinase Is a Novel Mediator of Myocardial Hypertrophy In Vivo Circ. Res., November 29, 2002; 91(11): 1007 - 1014. [Abstract] [Full Text] [PDF]

				Y. Hayashi, Y. Sawa, N. Fukuyama, H. Nakazawa, and H. Matsuda Preoperative Glutamine Administration Induces Heat-Shock Protein 70 Expression and Attenuates Cardiopulmonary Bypass-Induced Inflammatory Response by Regulating Nitric Oxide Synthase Activity Circulation, November 12, 2002; 106(20): 2601 - 2607. [Abstract] [Full Text] [PDF]

				M. Shimizu, M. Tamamori-Adachi, H. Arai, N. Tabuchi, H. Tanaka, and M. Sunamori Lipopolysaccharide pretreatment attenuates myocardial infarct size: A possible mechanism involving heat shock protein 70-inhibitory {kappa}B{alpha} complex and attenuation of nuclear factor {kappa}B J. Thorac. Cardiovasc. Surg., November 1, 2002; 124(5): 933 - 941. [Abstract] [Full Text] [PDF]

				M. Qing, J. F. Vazquez-Jimenez, K. Schumacher, R. S. Bhardwaj, B. Klosterhalfen, R. Minkenberg, B. J. Messmer, G. von Bernuth, and M.-C. Seghaye Moderate hypothermia during cardiopulmonary bypass increases intramyocardial synthesis of heat shock protein 72 J. Thorac. Cardiovasc. Surg., October 1, 2002; 124(4): 724 - 731. [Abstract] [Full Text] [PDF]

				Q. Xu Role of Heat Shock Proteins in Atherosclerosis Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1547 - 1559. [Abstract] [Full Text] [PDF]

				R. S. Decker, M. L. Decker, S. Nakamura, Y.-S. Zhao, S. Hedjbeli, K. R. Harris, and F. J. Klocke HSC73-tubulin complex formation during low-flow ischemia in the canine myocardium Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1322 - H1333. [Abstract] [Full Text] [PDF]

				K. Hirade, O. Kozawa, K. Tanabe, M. Niwa, H. Matsuno, Y. Oiso, S. Akamatsu, H. Ito, K. Kato, Y. Katagiri, et al. Thrombin stimulates dissociation and induction of HSP27 via p38 MAPK in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H941 - H948. [Abstract] [Full Text] [PDF]

				A. E. Kabakov, K. R. Budagova, D. S. Latchman, and H. H. Kampinga Stressful preconditioning and HSP70 overexpression attenuate proteotoxicity of cellular ATP depletion Am J Physiol Cell Physiol, August 1, 2002; 283(2): C521 - C534. [Abstract] [Full Text] [PDF]

				P. Eaton, W. Fuller, and M. J. Shattock S-Thiolation of HSP27 Regulates Its Multimeric Aggregate Size Independently of Phosphorylation J. Biol. Chem., June 7, 2002; 277(24): 21189 - 21196. [Abstract] [Full Text] [PDF]

				I. J. Benjamin and E. Christians Exercise, Estrogen, and Ischemic Cardioprotection by Heat Shock Protein 70 Circ. Res., May 3, 2002; 90(8): 833 - 835. [Full Text] [PDF]

				K. C. Kregel Molecular Biology of Thermoregulation: Invited Review: Heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance J Appl Physiol, May 1, 2002; 92(5): 2177 - 2186. [Abstract] [Full Text] [PDF]

				I. Kurucz, A. Morva, A. Vaag, K.-F. Eriksson, X. Huang, L. Groop, and L. Koranyi Decreased Expression of Heat Shock Protein 72 In Skeletal Muscle of Patients With Type 2 Diabetes Correlates With Insulin Resistance Diabetes, April 1, 2002; 51(4): 1102 - 1109. [Abstract] [Full Text] [PDF]

				H. Luss, W. Schmitz, and J. Neumann A proteasome inhibitor confers cardioprotection Cardiovasc Res, April 1, 2002; 54(1): 140 - 151. [Abstract] [Full Text] [PDF]

				L. Huang, N. F. Mivechi, and D. Moskophidis Insights into Regulation and Function of the Major Stress-Induced hsp70 Molecular Chaperone In Vivo: Analysis of Mice with Targeted Gene Disruption of the hsp70.1 or hsp70.3 Gene Mol. Cell. Biol., December 15, 2001; 21(24): 8575 - 8591. [Abstract] [Full Text] [PDF]

				J. Ohanian, P. Cunliffe, E. Ceppi, A. Alder, E. Heerkens, and V. Ohanian Activation of p38 Mitogen-Activated Protein Kinases by Endothelin and Noradrenaline in Small Arteries, Regulation by Calcium Influx and Tyrosine Kinases, and Their Role in Contraction Arterioscler Thromb Vasc Biol, December 1, 2001; 21(12): 1921 - 1927. [Abstract] [Full Text] [PDF]

				D. Hatakeyama, O. Kozawa, M. Niwa, H. Matsuno, K. Kato, N. Tatematsu, T. Shibata, and T. Uematsu Inhibition by adenylyl cyclase-cAMP system of ET-1-induced HSP27 in osteoblasts Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1260 - E1266. [Abstract] [Full Text] [PDF]

				T. Ooie, N. Takahashi, T. Saikawa, T. Nawata, M. Arikawa, K. Yamanaka, M. Hara, T. Shimada, and T. Sakata Single Oral Dose of Geranylgeranylacetone Induces Heat-Shock Protein 72 and Renders Protection Against Ischemia/Reperfusion Injury in Rat Heart Circulation, October 9, 2001; 104(15): 1837 - 1843. [Abstract] [Full Text] [PDF]

				L. H. E. H. Snoeckx, R. N. Cornelussen, F. A. Van Nieuwenhoven, R. S. Reneman, and G. J. Van der Vusse Heat Shock Proteins and Cardiovascular Pathophysiology Physiol Rev, October 1, 2001; 81(4): 1461 - 1497. [Abstract] [Full Text] [PDF]

				J. George, A. Afek, B. Gilburd, Y. Shoenfeld, and D. Harats Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice J. Am. Coll. Cardiol., September 1, 2001; 38(3): 900 - 905. [Abstract] [Full Text] [PDF]

				O. Eickelberg, J. Geibel, F. Seebach, G. Giebisch, and M. Kashgarian K+-induced HSP-72 expression is mediated via rapid Ca2+ influx in renal epithelial cells Am J Physiol Renal Physiol, August 1, 2001; 281(2): F280 - F287. [Abstract] [Full Text] [PDF]

				C. Depre, J. E. Tomlinson, R. K. Kudej, V. Gaussin, E. Thompson, S.-J. Kim, D. E. Vatner, J. N. Topper, and S. F. Vatner Gene program for cardiac cell survival induced by transient ischemia in conscious pigs PNAS, July 31, 2001; 98(16): 9336 - 9341. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Benjamin, I. J. Articles by McMillan, D. R. Search for Related Content PubMed PubMed Citation Articles by Benjamin, I. J. Articles by McMillan, D. R.